Horse Chestnut - Aesculus hippocastanum

Family: Sapindaceae (Horse-chestnut family) [Jepson] Hippocastanaceae [PFAF]

Google Gemini was used to create some tables and summaries. Due to the amount of the data, not all of it could be manually verified. (This page may require further scrutiny)

"Aesculus hippocastanum is a deciduous Tree growing to 30 m (98ft) by 15 m (49ft) at a fast rate.
It is hardy to zone (UK) 3 and is not frost tender. It is in flower in May, and the seeds ripen in September. The flowers are hermaphrodite (have both male and female organs) and are pollinated by Bees.[PFAF]
Suitable for: light (sandy), medium (loamy) and heavy (clay) soils, prefers well-drained soil and can grow in nutritionally poor soil. Suitable pH: acid, neutral and basic (alkaline) soils. It can grow in semi-shade (light woodland) or no shade. It prefers dry or moist soil. The plant can tolerates strong winds but not maritime exposure.
It can tolerate atmospheric pollution." [PFAF]

  • General: "A. hippocastanum grows to 36 metres (118 ft) tall, with a domed crown of stout branches; on old trees the outer branches often pendulous with curled-up tips.[3]" [Wiki]
  • Leaves: "The leaves are opposite and palmately compound, with 5-7 leaflets; each leaflet is 13-30 cm long, making the whole leaf up to 60 cm across, with a 7-20 cm petiole. The leaf scars left on twigs after the leaves have fallen have a distinctive horseshoe shape, complete with seven "nails". [3]" [Wiki]
  • Flowers: "The flowers are usually white with a small red spot; they are produced in spring in erect panicles 10-30 cm tall with about 20-50 flowers on each panicle. [3]" [Wiki]
  • Fruit: "Usually only 1-5 fruit develop on each panicle; the shell is a green, spiky capsule containing one (rarely two or three) nut-like seeds called conkers or horse-chestnuts. Each conker is 2-4 cm diameter, glossy nut-brown with a whitish scar at the base. [3]" [Wiki]
  • Organoleptic properties [dried ripe seed] Odour: slight; taste: bitter, acrid (1). [WHO SMPV.2]

Synonyms

  • Habitat / Range: Found under cultivation in Port Alberni, Tofino, Victoria. [Personal observation] Absent from [E-flora] & [PCBC] "Aesculus hippocastanum is native to a small area in the Pindus Mountains mixed forests and Balkan mixed forests of South East Europe.[5] However, it can be found in many parts of Europe as far north as Gästrikland in Sweden." [Wiki] "It is distributed in parts of the Balkan peninsula (Yugoslavia, Greece, Albania) and in one area in eastern Bulgaria (Tutin et al. 1968). It was introduced into central Europe in the 16th century and was extensively planted for ornament or shade in European and non-European countries. It is locally naturalized in western and central Europe." [Bajaj MAPS 7] "Aesculus hippocastanum is a tree which grows in Iran, Northen India, Asia Minor, and Southeast Europe from the Balkans to the Caucasus, as well as in the U.S.A." (kapusta2007)

Hazards & Toxicology: Aesculus hippocastanum

Critical Data Summary
General Toxicity Potentially toxic raw(254); requires professional supervision(254).[PFAF] Do not make tea out of raw, unprocessed horse chestnut seeds (McCaleb et al., 2000). [Bascom IHM]
Potential Allergen: Horse chestnut pollens are also a common cause of allergic condition in urban children.(28)[PSM Harmana] "Aesculin has caused contact dermatosis." [HMH Duke]
Pediatric Risk Untreated seed fatalities recorded[HMH Duke]. Ingestion threshold for pronounced symptoms: ~3–5 seeds[PDR][HMH Duke] or ~20 berries/fresh bark[PTH]. No therapeutic rationale for children[WHO SMPV.2].
Contraindications Kidney or liver disease(301); Warfarin therapy(301).[PFAF]; Pre-existing renal insufficiency[PDR].
Drug Interactions:
  • Anticoagulants/Salicylates: Increased bleeding risk(Jellin 2008)[Skidmore-Roth MHH][PDR].
  • Antidiabetics: Potentiates hypoglycemic effects(Jellin 2008)[Skidmore-Roth MHH].
  • Iron Salts: Tea decreases absorption; separate by 2 hours[Skidmore-Roth MHH].
Adverse Reactions:
  • Dermatologic: Pruritus[PTH]; Urticaria[PDR]; Itch[HMH Duke].
  • Gastrointestinal: Nausea[PDR][HMH Duke][PTH]; gastric complaints[PTH]; stomach upset (250-313mg non-controlled release)[Schulz RP]; GI mucosa irritation[PDR]; vomiting/diarrhea[PDR][HMH Duke].
  • Systemic/Acute: Severe thirst[PDR][HMH Duke]; face flushing[PDR][HMH Duke]; pupil enlargement[PDR][HMH Duke]; vision/consciousness disorders[PDR][HMH Duke].
  • Organ-Specific: decreased kidney function[PDR]; hepatotoxicity (leaf/intramuscular extract)[PDR].
  • Diagnostic: Alkaline urine may color red (Pseudohematuria)[PTH].
Saponins: Seeds rich in saponins[10][21][65]. Highly bitter; poorly absorbed by humans but toxic to fish[PFAF][K]. Saponins can be removed by leaching in running water or thorough cooking[PFAF]. "The saponins contained in non-controlled-release preparations of horse chestnut extract tend to cause stomach upset when the extract is taken at therapeutic doses of 250-313 mg twice daily, equivalent to 100 mg of aescin." [Schulz RP]
Clinical Feature Therapeutic Use (Processed HCSE) Toxicology (Raw/Unprocessed)
Safety Level Generally safe with supervision(254)[PFAF]. Therapeutic margin is ~8x lower than "no effect" dose[Schulz RP]. Potentially Fatal, especially in children (fatalities recorded)[HMH Duke].
Dosing Threshold Standardized extract typically 250–313 mg twice daily[Schulz RP]. Severe intoxication triggers at ~3–5 seeds in children[PDR][HMH Duke].
Gastrointestinal Isolated nausea or gastric distress[PTH][AEH]. Mucosal irritation, severe vomiting, and diarrhea[PDR][HMH Duke].
Organ Impact No cumulative toxic effects found in 34-week animal trials[HMH Duke][Schulz RP]. Risk of acute nephrotoxicity and hepatotoxicity[PDR].
Neurological None recorded at therapeutic levels. Mydriasis (enlarged pupils), vision disorders, and consciousness disorders[PDR][HMH Duke].

Treatment of Poisoning: "Following stomach and intestinal emptying (gastric lavage, sodium sulfate) and the administration of activated charcoal, therapy for poisonings consists of diazepam for spasms, atropine for colic, electrolyte replenishment and sodium bicarbonate infusions for any acidosis that may arise. Intubation and oxygen respiration may also be necessary." [PDR] "Ipecac/cathartic not recommended, activated charcoal/lavage (within 1 hour) may be useful; dilute with milk or water; activated charcoal or lavage if 3 or more seeds are ingested" [PTH]


Edible Uses

  • Seed: "The roasted seed is used as a coffee substitute[2, 7]. Seed - cooked. It can be dried, ground into a powder and used as a gruel[7, 46, 55, 61]. The seed is quite large, about 3cm in diameter, and is easily harvested. It is usually produced in abundance in Britain. Unfortunately the seed is also rich in saponins, these must be removed before it can be used as a food and this process also removes many of the minerals and vitamins, leaving behind mainly starch. See also the notes on toxicity." [PFAF] "The seed contains up to 40% water, 8 - 11% protein and 8 - 26% toxic saponins[218]. The following notes apply to A. californica, but are probably also relevant here:- The seed needs to be leached of toxins before it becomes safe to eat - the Indians would do this by slow-roasting the nuts (which would have rendered the saponins harmless) and then cutting them into thin slices, putting them into a cloth bag and rinsing them in a stream for 2 - 5 days[213]" [PFAF]

Horse chestnut seeds are considered inedible and poisonous. The bitter flavor prevents consumption of large amounts. The leaves, flowers, young sprouts, and seeds are toxic. [PSM Harmana] "Roasting horsechestnut appears to destroy its toxins." [Mills HMPL]

Other Uses

  • Soap: "Saponins in the seed are used as a soap substitute[169]" [PFAF]
  • Wood: "Soft, light, not durable. Of little commercial value, it is used for furniture, boxes, charcoal[2, 11, 46, 61]" [PFAF]
  • Dye: "A yellow dye is obtained from the bark[4]. The flowers contain the dyestuff quercetin[223]" [PFAF]
  • Repellent: "A macerate in water of some powdered horse-chestnuts was sprinkled on flowerpots to eliminate worms and insects (L)." (guarrera1999)
  • Tannin: "The bark and other parts of the plant contain tannin, but the quantities are not given[223]" [PFAF]
  • Papermaking; "Aesculus. Yellow buckeye (A. octandra) and its smaller associate, Ohio buckeye (A. glabra), are pulped in the United States. Perhaps common horse chestnut (A. hippocastanum) is used in southeastern Europe." (Irving H. Isenberg)

Medicinal Uses

Summarized Comparative Therapeutic & Pharmacological Data: Aesculus hippocastanum

Category Standardized / Proven Data Traditional / Folk Applications Pharmacological & Safety Parameters
Primary Indications Chronic Venous Insufficiency (CVI)(kapusta2007), [Barrett HCTHR], [HMH Duke], [Alachi IBM]
Varicosis & Leg Ulcers[PFAF], [HMH Duke]
Post-operative/traumatic edema(Shiyou Li et al. 2010), [PDR], [PSM Harmana]
Hemorrhoids (Internal/External)(APA, FAD, SKY, HMH Duke)
Rheumatism & Sciatica(Redzic 2007, HMH Duke, Saric-kundalic 2010)
Neuralgia & Lumbar Pain(APA, CRC, MAB, HMH Duke)
Gastrointestinal (Dysentery, Diarrhea)(PFAF, wilkinson1999, WHO SMPV.2)
Prostate Enlargement(wilkinson1999, CBMed)
Venotonic: Aescin reduces capillary filtration/fluid leakage(Alachi IBM).
Anti-edematous: Enlarges internal ureter diameter to facilitate stone passage(CBMed).
Cytotoxicity: Requires ~1000x therapeutic dose (~100g) for plasma concentration(Boik NCCT).
Part-Specific Utility Seeds (Ripe): Only part with clinically proven efficacy for CVI(Barrett HCTHR).
HCSE (Seed Extract): Safe alternative to compression stockings(Benzie HM).
Bark: Anti-inflammatory/Febrifuge; used for Malaria/Lupus(PFAF, HMH Duke).
Leaves: Tonic for Whooping Cough/Fever; unsubstantiated for Eczema/Arthritis(PFAF, PDR).
Roots: Powdered for analgesic treatment of chest pain(PFAF).
Seed Potency: 10 grains seed ≈ 3 grains opium (narcotic property)(PFAF 213).
Contraindication: Non-seed preparations (leaves, bark, flowers) no longer recommended for prescription(Schulz RP).
Dosage & Administration Oral Aescin: 30–150 mg/day (std); 40–120 mg/day for CVI/Hemorrhoids(PHR, HMH Duke, PDR).
Oral Extract: 250 mg twice daily(Alachi IBM) or 0.5–1.2 ml liquid seed extract(wilkinson1999).
Tincture (1:10): 0.6 ml for hemorrhoids(PDR).
Tincture (1:5): 5–15 ml/day(HMH Duke).
Bark Extract: 2–4 ml liquid(HMH Duke).
Homeopathic: 5 drops hourly (acute) to 1-3x daily (chronic)(PDR).
Topical: 1–2% aescin gel applied 4x daily for soft tissue/bruises; Do not apply to broken skin(PDR, Bascom IHM).
Harvest: Peak aescin in January; harvest occurs as fruit falls (Autumn)(Bajaj MAPS 7).

Additional Insights & Extended Indications

  • Inflammation & Trauma: Highly effective against blunt trauma, hematomas, joint sprains, and Achilles’ tendonitis(PSM Harmana).
  • Specific Conditions:
    • Dermatological: External use for Sunburn (APA, MAB) and Skin Ulcers (PFAF)(HMH Duke).
    • Urogenital: Treatment of chronic prostatitis (Russia) and supportive for menstrual spastic pain (unsubstantiated)(CBMed, PSM Harmana).
    • Renal: Aids the movement of ureteral stones and prevents recurrence of urolithiasis (gravel)(CBMed).
    • Viral/Oncology: Documented effects against viruses and tumors (PNC), though clinical evidence is restricted compared to CVI(HMH Duke, Duke).
  • Internal Medicine: Historically used for hardening of arteries (atherosclerosis) and coronary heart disease(PFAF, WHO SMPV.2).
  • Potency Comparison: 2 capsules of certified potency extract (18-22% aescin) often synergized with butcher’s broom, ginger, and rutin(HMH Duke).
  • Homeopathic Focus: Specifically addresses lumbar/low back pain and venous back pressure(PDR).

Bach Flower Therapy (Non-Pharmacological):
Chestnut Bud: Indicated for failure to learn from experience; harvested from twigs (15cm) prior to leaf unfolding(PFAF, Herbs2000).
White Chestnut (Flower): Indicated for persistent unwanted thoughts/mental arguments(PFAF).

Click to view original excerpts and notes
	

"The medicinal parts are the dried Horse Chestnut leaves, the oil extracted from the peeled fruit capsules (seeds) and dried chestnut seeds." [PDR]

"This tree produces large seeds commonly known as horse chestnuts or buckeyes. A number of reports dating from the early 18th century have indicated therapeutic properties for horse chestnuts. These have ranged from antifever to, at the end of the 19th century, antihemorrhoidal properties (2). Horse chestnut is most often used as a treatment for venous insufficiency. This is a condition associated with varicose veins, when the blood pools in the veins of the legs and causes aching, swelling, and a sense of heaviness." (kapusta2007)

"In Europe, the bark, leaves, horse chestnut seed extract (HCSE), and aescin (a saponin mixture) from A. hippocastanum have been used in the treatment of chronic venous insufficiency, hemorrhoids, and postoperative edema 5-9." (Shiyou Li et al.,2010)

"The plant is taken in small doses internally for the treatment of a wide range of venous diseases, including hardening of the arteries, varicose veins, phlebitis, leg ulcers, haemorrhoids and frostbite238, 254. It is also made into a lotion or gel for external application254." [PFAF] Other (Non-seed) preparations made from horse chestnut leaves, bark, and flowers have been negatively appraised and should no longer be prescribed. [Schulz RP]

"The German Commission E recommends a dry extract manufactured from horse chestnut seed for the treatment of complaints found in pathological conditions of the veins of the legs (chronic venous insufficiency), for example, pains and a sensation of heaviness in the legs, nocturnal systremma (cramps in the calves), pruritus, and swelling of the legs (Blumenthal et al., 1998). The European Scientific Cooperative on Phytotherapy (ESCOP) also suggests horse chestnut for the treatment of chronic venous insufficiency, as well as for varicosis (ESCOP, 1999)."[Barrett HCTHR]

"Extracts of the seeds of Aesculus hippocastanum (horse chestnut) are a well established treatment for conditions such as varicose veins, haemorrhoids, phlebitis (inflammation of the veins), diarrhoea, fever, enlargement of the prostate gland [2], rheumatism, neuralgia and rectal complaints [3]. Such treatments are usually administered orally, at a dose of 0.5–1.2 ml of liquid seed extract per day." (wilkinson1999)

  • Bark: "The bark is anti-inflammatory, astringent, diuretic, febrifuge, narcotic, tonic and vasoconstrictive[4, 7, 222]. It is harvested in the spring and dried for later use[4]." [PFAF]
    • Tea: "A tea made from the bark is used in the treatment of malaria and dysentery, externally in the treatment of lupus and skin ulcers[4, 222]." [PFAF]
  • Fruit: The pericarp [Entire fruit, without seed] is peripherally vasoconstrictive[7] [PFAF]
  • Seeds: "They have been used in the treatment of rheumatism, neuralgia and haemorrhoids[4]. They are said to be narcotic and that 10 grains of the nut are equal to 3 grains of opium[213]" [PFAF] "As early as the 1800s, horse chestnut seed extracts were used therapeutically in France. Although preparations of other parts of the tree have been used medicinally, only the efficacy of the dried seeds has been proven." [Barrett HCTHR]
    • Harvesting: "The suitable time for collection of the drug coincides, according to the literature, with the period when the fruit falls in autumn. However, the season when the seed has its maximum content of aescin is the month of January; the content declines both before and during seed germination. (Profumo et al. 1987a)." [Bajaj MAPS 7]
    • Rheumatism: "Fruits of wild chestnut Aesculus hippocastanum are being carried in the pockets by people who suffer chronic rheumatism and sciatica." (Redzic,2007)
    • Unproven uses: "Horse Chestnut seeds are used for symptoms of post-traumatic and post-operative soft tissue swelling. Further indications are painful injuries, sprains, bruising, pain syndrome of the spine, edema, rheumatic disease and varicose veins."[PDR]
    • Oil: "An oil extracted from the seeds has been used externally as a treatment for rheumatism[254]" [PFAF]
    • Homeopathic treatments include hemorrhoids, lumbar and low back pain, venous back pressure. [PDR]
    • Preparation: "A dry extract is manufactured from Horse Chestnut seeds standardized to a content of 16-20% triterpene glycosides (calculated as anhydrous aescin). [PDR] Stabilized extract of Horse Chestnut (5:1 ) is standardized for aescin; tincture of Horse Chestnut 1:1 with 75% ethanol; isolated aescin." [PDR]
    • Daily Dosage: "Oral—Aescin from encapsulated standardized extracts are initially given at doses of 10 mg (Chandler, 1993). The encapsulated standardized extract has been used for the treatment of postoperative or traumatic edema, hemorrhoids or symptoms due to varicose veins in doses providing 40 to 120 mg of aescin per day (Schlesser, 1991). Aescin (escin) 100 mg corresponding to 250-312.5 mg extract may be administered twice daily in delayed-release form." [PDR]
      • Tincture— "For the treatment of painful hemorrhoids, a dose of 1:10 tincture is 0.6 ml (Reynolds, 1977)." [PDR]
      • Topical— "A 1 to 2% gel is applied topically several times daily for soft tissue injuries, bruises and symptomatic relief of varicose veins..." [PDR]
    • Homeopathic Dosage: "5 drops, 1 tablet or 10 globules every 30 to 60 minutes (acute) and 1 to 3 times daily (chronic); parenterally: 1 to 2 ml 3 times daily sc; ointment 1 to 2 times daily (HAB1)." [PDR]
    • Storage: The herb should be stored in a dry and dark place.[PDR]
  • Root: "A compound of the powdered roots is analgesic and has been used to treat chest pains[257]" [PFAF]
  • Leaves: "A tea made from the leaves is tonic and is used in the treatment of fevers and whooping cough[222, 240, 254]" [PFAF]
    • Indications: "Venous conditions (chronic venous insufficiency) Treatment of symptoms found in pathological conditions of the veins of the legs (chronic venous insufficiency), for example pain and a sensation of heaviness in the legs, nocturnal cramps in the calves, pruritis and swelling of the legs." [PDR] "Leaf preparations used in European traditions for eczema, varicose veins, supportive treatment of varicose ulcers, phlebitis, thrombophlebitis, hemorrhoids, menstrual spastic pain, soft tissue swelling from bone fracture and sprains, and other uses. Effectiveness of leaf preparation claims is unsubstantiated.[34]" [PSM Harmana]
    • Unproven Uses: "Eczema, superficial and deep varicose veins, leg pains, phlebitis, hemorrhoids, pains before and during menstruation. In folk medicine, the leaves are used as a cough remedy, as well as for arthritis and rheumatism." [PDR]
    • Mode of Administration: "Extracts of the drug are contained in "vein teas" or "hemorrhoid teas," as well as in pharmaceutical preparations for the treatment of venous symptoms." [PDR]
    • Preparation: One ampule corresponds to 4 mg flavones in 0.9% NaCl [PDR]
    • Daily Dosage: Infusion (as a tea)—Pour boiling water over 1 tsp. of finely cut drug and strain after 5 to 10 minutes (ltsp = 1 gm drug).[PDR]
  • Bach: "The buds are used in Bach flower remedies - the keywords for prescribing it are 'Failure to learn by experience', 'Lack of observation in the lessons of life' and hence 'The need of repetition'[209]. The flowers are used in Bach flower remedies - the keywords for prescribing it are 'Persistent unwanted thoughts' and 'Mental arguments and conversations'[209]" [PFAF]
    • Preparation: "To prepare this Bach Flower Remedy, you need to pick the entire twig, roughly 15 cm in length, while the shoot has come out of the bud, but prior to the unfolding of the leaves. In fact, this is a specific phase of development that needs to be carefully watched. Initially the buds distend and subsequently, the gummy scales drop behind and finally the shoot emerges from the bud. It may be noted even the resins or the sap are also an element of this flower essence remedy, though they mess up the saucepan, which will require scouring with a cleaner." [Herbs2000]
    • Uses "A Bach Flower Remedy, Chestnut Bud is especially indicated for the youthful and reckless mind that is not predisposed to put together the experiences of every day life. It is also a valuable remedy for curing the condition wherein an individual is unable to take lessons from earlier mistakes in his or her life." [Herbs2000]

"Dosages (Horse Chestnut) — 0.2–1.0 g fruit 3 ×/day (CAN); 1–2 g dry seed/day (MAB); 1/2 tsp powdered seed/16 oz water (APA); 2–6 ml fluid seed extract (1:2)/day (MAB); 5–15 ml/day seed tincture (1:5) (MAB); 2–4 ml liquid bark extract (PNC); 0.5–1.2 ml liquid fruit extract (PNC); 30–150 mg aescin/day (PHR); 90–150 mg aescin at first, then 35–70 mg (APA); 300–600 mg StX ( = 100 mg aescin) (SHT); StX tablets (200 mg concentrated 5:1 extract) to provide 40 mg escin, 2–3 ×/day (MAB); 2 (480 mg) capsules (StX with 257 certified potency extract with at least 18–22% triterpenoid glycosides (calculated as aescin) synergistically combined with butcher’s broom, ginger, and rutin), one with morning meal, one with evening meal (NH)."[HMH Duke]

  • Gel or lotion: Apply 2 percent aescin gel or lotion topically four times a day to bruises, strains, sprains, and varicose veins. Do not apply gel to broken skin.[Bascom IHM]
  • Anticancer: "Because of the poor pharmacokinetic characteristics of escin, cytotoxic concentrations can probably not be achieved in the plasma. Indeed, based on pharmacokinetic and in-vitro data, the cytotoxic dose appears to be about 100 grams, which is 1,000-fold higher than the dose commonly prescribed in noncancerous conditions. Therefore, escin is best used for its potential to inhibit cancer progression by indirect means. The commonly prescribed escin dose in noncancerous conditions is 100 to 150 milligrams per day. This dose might be sufficient to cause anticancer effects through indirect actions, if horse chestnut is used with other anticancer compounds." [Boik NCCT]
  • CVI: "Chronic venous insufficiency is due to venous hypertension associated with venous valvular reflux.58 Horse chestnut (Aesculus hippocastanum) has traditionally been used for strengthening and healing veins affected by this condition. Supporting the traditional use, clinical studies have shown improvement in this condition with the use of horse chestnut extracts.58 The activity of horse chestnut is due to the presence of the principle component aescin (or escin) which aids in reducing fluid leakage from the vessel walls and helps to strengthen them.28 A review of clinical trials comparing oral administration of horse chestnut extract to placebo revealed a significant measurable reduction in leg pain and swelling with the extract.59 Extracts from the seeds of horse chestnut can be given internally or applied as a poultice to the affected area.28 The recommended dose for chronic venous insufficiency is 250 mg twice daily.60" [Alachi IBM] "Horse chestnut seed extract (HCSE) is one of the most researched herbal alternatives.... Rates of reported adverse effects were from 0.9% to 3.0% and in several studies were not statistically different from rates of adverse effects observed with placebo. Although there are no long-term studies of orally administered HCSE in treating CVI and its sequelae, these results seem promising and offer patients a safe alternative to compression stockings." [Benzie HM]
  • Edema: Horse chestnut extract is effective against many forms of edema, including brain edema. [Boik NCCT]
  • Kidney Stones: "In the case of calculi caught in the ureter, horse chestnut’s anti- edematous effects enlarge the internal diameter of the ureter. As a result the stone can move more easily, even in resistant cases. In preventing recurrences of urolithiasis, horse chestnut appears to help gravel pass smoothly. In some cases this formula has helped to break up stones that are then passed in smaller pieces. It is important to remind the patient to urinate through a fine screen, or, if that is not available, to urinate into a jar. When the stone passes into the jar, it will often make an audible sound permitting a subsequent analysis of the stone." [CBMed]
  • Prostatitis: "Aesculus hippocastanum (horse chestnut) seed extract has also been evaluated in an uncontrolled trial in Russia for men with chronic prostatitis.[29] Though details are not available this extract was apparently effective at relieving symptoms."[CBMed]
  • "Traditional uses of horse chestnut include treatment of fever, phlebitis, hemorrhoids, prostate enlargement, edema, inflammation, and diarrhea. It is commonly used in Germany to treat varicose veins." [Skidmore-Roth MHH]
  • "Uses described in pharmacopoeias and in traditional systems of medicine [dried ripe seed] Treatment of coronary heart disease (25)."[WHO SMPV.2]
  • "Uses described in folk medicine, not supported by experimental or clinical data [dried ripe seed] Treatment of bacillary dysentery and fevers. Also as a haemostat for excessive menstrual or other gynaecological bleeding, and as a tonic (6)." [WHO SMPV.2]

Topical/Cosmetic Preparations

"Medicinal, Pharmaceutical , and Cosmetic. Horse chestnut extract or aescin (0.25–0.5%) has reportedly been used in shampoos, shower foams, foam baths, skin care products, body and hand creams, lotions, and toothpastes. Cosmetic use in Europe has been based on its clearing and redness reducing properties, and its effectiveness in preventing cellulitis.[29]"[PSM Harmana]

"Numerous clinical studies and published case reports confirm the efficacy of aescincontaining topical products, especially in the treatment of sport injuries, including blunt trauma of the lower limbs,[30] joint sprains, tendonitis, hematomas, muscle strain, traumatic edema,[31] Achilles’ tendonitis; surgical outpatient trauma, including fractures, sprains, crush injuries, and contusions;[32] postoperative or postpartum edema in obstetrics and gynecology;[12] and others."[PSM Harmana]

Aesculus hippocastanum L. (FABAES) - Bark and leaves - Ointment made by mixing the decoction with olive oil or pig fat - Anti-haemorrhoids (Pieroni, Andrea, et al.)

flowers, fruits, buds; "Tea for rheumatism. Tincture for varicose veins, blood circulation disorders, hemorrhoids, intestinal and pulmonary ailments. Fresh plant for high fever. Fluid unction for varicose veins" (Saric-kundalic et al., 2010)

Indications

Venous effects

"One of the most widely used applications of A. hippocastanum is in the treatment of poor circulation, and its associated conditions. Whilst many of these studies rely on oral delivery of the extracts to improve circulation, conditions such as varicose veins, phlebitis and post-thrombotic syndrome have all been treated using gels containing escin [5, and refs. therein], suggesting that the topical administration of extracts, as would be the case in the application of cosmetics, is potentially an equally valid delivery system. The positive effects of A. hippocastanum extracts on circulation are due to a range of complex interactions with veins, the lymphatic system, capillaries and connective tissue. Extracts of A. hippocastanum have been demonstrated to possess venotonic effects in vitro and in vivo, in both animal and human systems [5, and refs. therein]. For example, A. hippocastanum extract led to an increase in pressure of flow through both normal and constricted isolated veins, and an increased effect of noradrenaline on increasing the blood pressure (and consequently flow) through such vessels [18]. Similarly, capillaries have been shown to be strengthened by administration of A. hippocastanum extract. In addition to the direct effects of A. hippocastanum extract on blood vessels, benefit may also be gained from the protective effects of the extract on connective tissues which surround the capillary vessels. In chronic venous insufficiency, the capillaries become highly permeable, resulting in water and proteins leaving the vascular system, which in turn cause swelling; this may be as a result of the degradation of the extracellular matrix surrounding the microvasculature (Figure 5). The main component of this extracellular matrix is hyaluronic acid, a simple glucosaminoglycan consisting of up to several thousand sugar residues; levels of this compound are usually regulated by the enzyme hyaluronidase, which promotes the degradation of hyaluronic acid. Recently, escin and its aglycone, escinol, have been demonstrated to possess non-competitive antihyaluronidase activity (Table IV), even at concentrations well below that expected as a result of topical application of these compounds [11]. This inhibition of hyaluronidase should lead to the recovery of the integrity of hyaluronic acid, and consequently the extracellular matrix surrounding the micro- vasculature, and may therefore be responsible for some of the beneficial effects of A. hippocastanum extracts." (wilkinson1999)

"One of the conditions associated with venous insufficiency is the development of oedematous panniculopathies (inflammation of the sub-cutaneous layer of fat, leading to tender nodules, typically on the thighs and breasts), and this condition has recently been treated with phytochemicals from horse chestnut. Application of an emulsion containing escin and biological carriers, such as β-sitosterol and phosphatidylcholine, over a 30 day treatment period, led to significant improvements to both thigh and breast pauniculopathies in human volunteers. These improvements were ascribed to improvements in micro- circulation, as recorded by Laser Doppler Flowmetry, resulting in reduced swelling and normalisation of skin temperature...." (wilkinson1999)

"In addition to the existing uses of extracts of horse chestnut as treatments for venous insufficiency, preparations containing phytochemicals from horse chestnut have consider- able potential for inclusion in a range of cosmetic formulations. Inclusion of horse chestnut extracts (especially those from the seeds of the plant, rather than the more poorly- characterised extracts from leaf and bark tissue) could result in a number of beneficial actions on the skin after topical administration. Such effects would include potent anti- oxidative activity, which could help decrease the visible signs of skin ageing, anti-bacterial and anti-viral properties (largely due to flavonoids), reduction in skin reddening and cutaneous swelling as a result of effects on capillary vessels and their surrounding con- nective tissues (due to saponins and the epicatechin dimer proanthocyanidin A2) and also the potential synergistic enhancement of the efficacy (SPF) of sun screens." (wilkinson1999)

Existing cosmetic applications

"In 1980, the applications of horse chestnut and escin to cosmetic products were described for treating the following areas: scalp, oral cavity, face, body, hands, legs and feet, body hygiene, foot hygiene, intimate hygiene and prevention of haemorrhoids [14]. Recently, it has been reported that extracts of horse chestnut [or escin at 0.25–0.5% (w/v)] have been included in a range of commercial products which apply to these areas, including shampoos, shower foams, foam baths, creams, lotions and toothpastes [15]. Horse chestnut seeds are on the Medicines Control Agency’s General Sales List in the UK [2] for external use only. In Germany, they are the subject of a positive therapeutic monograph, indicated for venous insufficiency, although in the United States, they are of undetermined regulatory status [15]." (wilkinson1999)


Actions

"Horse chestnut is an astringent, anti-inflammatory herb that helps to tone the vein walls which, when slack or distended, may become varicose, haemorrhoidal or otherwise problematic[254]. The plant also reduces fluid retention by increasing the permeability of the capillaries and allowing the re-absorption of excess fluid back into the circulatory system[254]." [PFAF]

"The extracts of horse chestnut show beneficial effects on venous insufficiency and have many positive pharmacological effects on the skin 5. The aescin is a potent anti-inflammatory principle, which also reduces capillary fragility and prevents leakage of fluids into surrounding tissues. These saponins have also been used in shampoos, shower foams, creams, lotions, and toothpastes." (kapusta2007)

"Some different specialties, containing bioactive principles from horse-chestnut (tree bark, bud, flowers and other parts, may be safely used for specific targets) are now commercially available in the world (Deli, Matus, and Toth, 2000). So, among others, we appraise that some saponin constituents, also named escins, extracted from Aesculus hippocastanum L. seeds, have shown satisfactory evidence for a significant clinical activity in some specific therapies. The same is valid for oil extracted from the seeds, that gives some other benefits on therapeutic treatments. Furthermore, it has been proven by many clinical trials that these natural extracts are effective adjuvants in compression therapy as an alternative medical treatment (Sirtori, 2001), in addition to an ethanol absorption-inhibitory effect and hypoglycemic activity (Yoshikawa et al., 1996). Moreover, it has been described in the literature by Konoshima and Lee (1986) the cytotoxic and antitumoral activity of some sapogenols extracted from Aesculus hippocastanum L., in particular hippocaesculin and barringtogenol-C." (baraldi2007)

Anti‐elastase and anti‐hyaluronidase activities

"Triterpene and steroid saponins and sapogenins of medicinal plants (Aesculus hippocastanum L., Hedera helix L., Ruscus aculeatus L.) are claimed to be effective for the treatmen/prevention of venous insufficiency." (facino1995)

"Constituents from Aesculus hippocastanurn L. show inhibitory effects only on hyaluronidase, and this activity is mainly linked to the saponin escin (IC50 = 149.9 μg), less to its genin escinol (IC50 = 1.65 mM)." (facino1995)

"Their active constituents are saponins and sapogenins with different chemical structures: triterpene (escin and escinol from Aesculus hippocastanum L. seeds, ...." (facino1995)

"Both the saponins Hederacoside C and a-hederin had no anti-hyaluronidase activity. By contrast, of the active principles of Aesculus hippocastanurn L., Escin had the highest activity (IC50= 149.9 μg), inhibiting hyaluronidase from 50 μg (4.2 +/- 0.6 % inhibition); at higher concentrations 100, 150, 200, and 300 μg, the enzyme activity was inhibited by 27.4 +/- 2.2 %, 52.0 +/- 2.4 %, 79.2 +/- 4.2 % and 93.6 +/- 3.4 % respectively (Fig. 4). The aglycon escinol was much less active (IC50 = 1.65 mM), and the ruscogenins were totally ineffective." (facino1995)

"Escin and escinol have no anti-elastase activity: they inhibit only lysosomal hyaluronidase, probably through a cooperative mechanism (aglycone plus glycoside). The weak inhibition by escin observed in vitro compared with the remarkable venotonic, vasculotropic and anti-exudative activity found in vivo in animal models 21, indicates that this saponin can affect other enzymes of the extravascular matrix (collagenase, P-glucuronidase) and/or acts through other mechanisms (such as those involving inhibition of prostaglandin and leukotriene synthetases)." (facino1995)

Pharmacological Activity Profile

Categorized Biological Effects & Clinical Indications

Analgesic & Anti-inflammatory
Cardiovascular & Hematological
Systemic & Metabolic
Cellular & Antiviral
Respiratory & Sensory
Tissue & Structural
Note: Numerical values (1, 2) and alphabetical codes (f, CAN, CRC, etc.) refer to activity levels and specific database source coding. f = folklore, not yet substantiated.

Seed Saponins

"Although other constituents may have some bioactivity, the polyhydroxylated triterpenoid glycosides (saponins) in Aesculus extract are considered to be the major active principles. To date, the saponins from the seeds of six species including A. hippocastanum (AH), A. chinensis var. chinensis (ACC), A. chinensis var. wilsonii (ACW), A. turbinata (AT), A. assamica (AA), and A. pavia (AP) have been well documented. Very interestingly, the saponins from four Eurasian species (AH, ACC, ACW, and AT) have very similar structures but are different from the novel cytotoxic saponins from an eastern North American species A. pavia. This chemical difference suggests a chemotaxonomic significance between the two groups 13, 61." (Shiyou Li et al.,2010)

"As found in different animal tests and preclincal investigations, the principal ingredient of Horse Chestnut seed extract, triterpene glycoside mixture (aescin), has an anti-exudative, vascular tightening effect, and reduction of vascular permeability which result in an antiedemic effect. The vein-toning properties of the Horse Chestnut extract also demonstrated improvement of venous return flow. A significant reduction of transcapillary filtration was seen in a placebo-controlled human pharmacological trial (Bisler, 1986). Significant improvement in the symptoms of chronic venous insufficiency was demonstrated in diverse, randomized, double-blind and cross-over studies (Calabrese, 1993; Steiner, 1990). There are indications that Horse Chestnut seed extract reduces the activity of lysosomal enzymes, which increases in chronic pathological conditions of the veins. The enzymes will break down glycoacalyx (mucopolysaccharides) in the region of the capillary walls, allowing proteins to leak into the interstitium. The activity of the enzymes is reduced by the aescin and so the breakdown of glycoacalyx is also inhibited. The transcapillary filtration of low-molecular proteins, electrolytes and water into the interstitium is inhibited through a reduction of vascular permeability by the aescin." [PDR]

"The horse chestnut extracts have been demonstrated to be a potent scavenger of active oxygen. This showed the highest activity of 65 plant extracts tested, was more powerful than vitamin E, and exhibited a potent cell-protective effect linked to antiaging properties of antioxidants 6. The major principles of these activities are flavonoids present in the extracts. This group of secondary metabolites shows radical scavenging, antibacterial, and antiviral activities, and they are used in varicosis and capillary fragility. Recent work on flavonoids from the seeds of Aesculus chinensis demonstrated their activity against parainfluenza virus type 3 and influenza virus type A 6. Regarding the flavonoids from Aesculus hippocastanum, literature provides inconsistent data. The detailed work on structural characterization of flavonoids was performed by Hübner and co-workers and showed that they were glycosides of quercetin and kaempferol and some of them occurred as acylated forms 8. In the conclusion of this work, however, the authors pointed out that the concentration of these compounds in horse chestnut seeds is low (0.3%, calculated as rutin equivalent) and their contribution to the therapeutic efficacy of crude drug is unlikely. This statement remains inconsistent with the literature data cited above indicating the main role of horse chestnut flavonoids in radical scavenging activity of the extracts." (kapusta2007)

"Aesculin extracted from the Horse Chestnut (Aesculus hippocastanum) goes into the phytotherapeutic preparations for the treatment of capillary fragility." (gurib-fakim2006)

"The anti-inflammatory activities are often attributed to the presence of saponins while the antioxidant activity attributed to the presence of flavonoids and other molecules having antioxidant activities. Among the plants that have contributed shown prominence are: Horse chestnut (Aesculus castanea) and Gingko (Gingko biloba)." (gurib-fakim2006)

"Traditionally, the dried ripe seeds have been used in the treatment or coronary heart disease. The main constituents are the triter- pene saponins (up to 10%) and are collectively known as Aescin (a-aescin, b-aescin and cryptoaescin) and they are considered to be the major therapeutic principles of the seeds. b-Aescin is a mixture of more than 30 different glycosides derived from the triterpene aglycones protoaescigenin (also known as protoescigenin) and barrintogenol C. Other constituents present include the flavonoids (e.g. quercetin, kaemferol and their glycosyl derivatives)." (gurib-fakim2006)

"Hydroalcoholic extracts of the seeds have been tested in canine saphenous veins in vitro, and an intravenous bolus (25–30 mg) increased venous pressure in perfused canine saphenous veins, in vivo. Placebo-controlled clinical trials have been carried out to assess the efficacy of oral administration of standardized extracts (250– 600 mg) equivalent to 100–150 mg aescin daily, in the treatment of Chronic Venous Insufficiency (CVI). Clinical studies have shown symptomatic improvement in skin colour, venous prominence, oedemas etc in treated patients. Pregnancy-related varicose veins in women, swollen legs during long (15 h) flights also responded positively to treatment. Double-blind placebo-controlled in healthy volunteers also showed improvement in capillary- resistance (WHO, 2002)." (gurib-fakim2006)

"We investigated the anti-inflammatory activities of the pure escins in acute inflammatory models. Escins dose-dependently exhibited inhibitory effects on the increase of vascular permeability by acetic acid in mice, and on the earlier phase of swelling by carrageenin in rats. Escins also inhibited histamine- or serotonin- induced increase of vascular permeability, excepting escin Ia on serotonin-inducedone. Escin Ib (2) showed significant inhibition on the second phase of swelling by carrageenin, and escins IIa (3) and IIb (4) also showed tendency to inhibit it. These results indicate that escins, given orally, effect on the early exudative stage of inflammation and itch owing to these chemical mediators and suggest that these inhibitory effects are mainly depend on their anti-histaminic and anti-serotonic activities, though the effects of escins against kinin formation and arachidonic acid cascade are not clarified." (matsuda1997)

"In this study, it has become apparent that escins have antiinflammatory activities in the acute stage, but there are differences among the activities of escins, especially anti-serotonic activity. Furthermore the differences of chemical structure in acyl groups and in oligosaccharide moiety are apparently be important to exhibit the antiinflammatory activity." (matsuda1997)

"The therapeutic benefits of HCSE and aescin for the treatment of chronic venous insufficiency, hemorrhoids, and postoperative edema are due to their significant antiinflammatory properties, which were demonstrated in animal models 5, 50, 84, 85]. The anti-inflammatory activities of HCSE or aescin are related to the molecular mechanism of the agents, which include the improved entry of ions into channels 86 thus raising venous tension 87, the release of prostaglandin-F2a from veins 88, the release of inflammatory mediators by decreasing leukocyte activation and adhesiveness 84, 89, the antagonism to the pro-inflammatory 5- HT receptors and histamine 90, and the decrease in the activity of tissue hyaluronidase 91." (Shiyou Li et al.,2010)

Dry Extract

"... pharmacopeiae report only few information about the grade quality of horse-chestnut seeds, which is the most widely used starting material required for manufacturing the above specified native dry extracts. These pharmacopeiae establish that the dry extracts, from the dried seeds of Aesculus hippocastanum L., must contain not less than 3.0% of triterpene glycosides, calculated as anhydrous escin, with reference to the dried drug." (baraldi2007)

"The typical drug-to-extract ratio for this native dry extract, will fall within the range of 5.0–8.0:1 (w/w), depending on the chemical composition of the starting material and the subsequent yield of soluble extractive." (baraldi2007)

Antiviral and Antifungal Activities

"Isoescins Ia (43) and Ib (44) and escins Ia (21), Ib (22), IVc (28), IVd (29), IVe (30), and IVf (31) isolated from the seeds of A. chinensis var. chinensis showed activity against HIV-1 protease. Escins Ia (21) and Ib (22) inhibited the enzyme’s activity by 86.1 ± 0.2% at 100 µM with IC50 values of 35 and 50 µM, respectively, while saponins 28-31, 43, and 44 showed weaker antiviral activity 47. Three flavonol glycosides of aescuflavoside (103), aescuflavoside A (105), and leucoside (120) from A. chinensis var. chinensis showed significant antiviral activities against respiratory syncytial virus with IC50 values of 4.5, 6.7, and 4.1 µg/mL, and selective index values of 15.8, 32, and 63.8, respectively. Astragalin (122) demonstrated significant antiviral activity against influenza virus type A with an IC50 of 24.5 µg/mL and a selective index of 16.0 66. Pavietin (161), a new prenylated coumarin, isolated from the leaves of a genotype of A. pavia, showed antifungal activity. In a preliminary antifungal screening by filter disk method, pavietin (15 mg/dish) possessed significant activity against an Aesculus-specific fungal parasite, Guignardia aesculi, and weaker activity against the generalist polyphagous Pythium ultimum and the Aesculus nonpathogenic Fusarium basilici. More detailed antifungal screening by adding pavietin to mycelial growth medium of different fungal pathogens showed that pavietin exhibits appreciable antimicrobial properties against several pathogens including Alternaria alternata, A. dianthi, Aspergillus niger, Botrytis cinerea, Cladosporium fulvum, Fusarium oxysporum dianthi, Guignardia aesculi, Penicillium expansum, Polyporus marginatus, Rhizopus stolonifer, and Trichoderma viride 67." (Shiyou Li et al.,2010)

Antibacterial

"Slimy bacteria Sporocytophaga species was reported to be inhibited by the leaf extracts of Aesculus hippocastanum and Acer platanoides, which contain considerable amounts of polyphenols, tannic acids, coumarin, and flavonoglucids.219 Field and Lathinga220 reported that the growth of methanogenic bacteria was affected by tannins." (chung1998)

"...we mention that Fant, Vranken, and Borremans (1999) report that antimicrobial protein 1 (Ah-AMP1), isolated from horse-chestnuts and whose structure has been resolved via 1H NMR techniques, is a very effective plant defence in that it inhibits growth of a broad range of fungine species." (baraldi2007)

Anti-ageing effects

"Many reports suggest a link between skin ageing and active oxygen species, especially when combined with ultra-violet radiation. Recently, an extract of A. hippocastanum has been shown to be highly effective in reducing the production and damaging effects of active oxygen species in vitro, using both biochemical and biological assays 16." (wilkinson1999)

"In vitro active-oxygen-scavenging properties of A. hippocastanum. An extract of A. hippocastanum has been demonstrated to be a ‘potent scavenger’ of active oxygen, being almost 20 times more effective at absorbing superoxide anions than ascorbic acid, a recognised anti-oxidant 16.... Similarly, the extract of A. hippocastanum reduced the release of hydroxyl radicals and singlet oxygens in vitro, demonstrating a broad spectrum of active oxygen scavenging properties .... As these oxygen species are associated with cellular damage and inflammation, their absorption by cosmetic preparations containing horse chestnut phytochemicals has great potential to alleviate damage to the skin, which could ultimately be manifested as an anti-ageing effect." (wilkinson1999)

"In vitro cell-protective effects of A. hippocastanum. Lipid peroxidation, a process indicative of damage to cellular membranes, was induced in vitro, under controlled conditions, and was found to be significantly reduced in experiments using A. hippocastanum extracts 16. Such inhibition was comparable to that obtained by including the anti-oxidant α-tocopherol in the assay. Cultured fibroblasts, which are cells usually found in the connective tissue secreting a matrix associated with the repair and isolation of wounded tissues, were also strongly protected by the extract of A. hippocastanum from damage caused by active oxygen species in vitro. Almost four times the number of these cells survived damage induced by oxygen species, generated using the hypoxanthine/xanthine- oxidase system, in the presence of the A. hippocastanum extract than when the extract was absent." (wilkinson1999)

Solar protective effects

"Closely linked to the anti-ageing effects of A. hippocastanum are its potential applications in cosmetics with sun-screen properties. A recent study 17 has investigated the potential use of plant extracts, including A. hippocastanum seed extract, as novel ‘anti-solar’ agents, based on their ability to absorb light. Such absorption is of particular interest in the ultraviolet region of the spectrum, as UV radiation has been linked with a number of cutaneous conditions, including sunburn, photosensitivity, actinic elastosis, cutaneous degeneration and perhaps most importantly, skin cancer 10, 17.
Although an extract of A. hippocastanum did not display significant UV-absorbing properties when studied in isolation (in which it had a sun protection factor (SPF) of 0), when combined with a synthetic sunscreen, octylmethoxyciunamate, significant increases in the effectiveness of the synthetic compound were demonstrated (SPF rose from 4 to 6 on the addition of the A. hippocastanum extract; Table III). Whilst the precise reasons for this improvement of SPF remain unresolved, the authors speculated that such an increase may be as a result of synergistic interactions between components of the A. hippocastanum extract and octylmethoxycinnamate 17." (wilkinson1999)

Horse Chestnut Leaf

"The main active principles of the anti-exudative effect and improvement of venous tone are hydroxycoumarins (aesculin and fraxin), triterpene saponins in the petioles and leaf veins, flavonoids and a rich supply of tannins. Although the drug is said to have an anti-exudative effect and improve venous tone, there is a lack of clinical data to support the efficacy."[PDR]

Antitumor Activity Research

Mechanisms of Action & Clinical Potential

Can Aesculus treat cancer?
Research indicates that β-escin and specific acyl-saponins possess significant antitumor properties. While much research is in vitro (petri dish), animal studies have shown promising results. For example, Aescin from A. chinensis var. wilsonii demonstrated a 43.5% inhibition rate on H22 tumor growth in mice at doses of 2.8 mg/kg. However, because effective cytotoxic doses in humans are estimated to be high, these compounds are currently viewed as potential inhibitors of cancer progression rather than standalone cures.

Mechanism 1: The "Stop" Signal

G1-S Cell Cycle Arrest

Target: Colon Cancer (HT-29), Leukemia

β-escin acts like a brake pedal at the G1-S Phase checkpoint. It prevents the cell from moving from "Growth" to "DNA Replication" by:

  • Boosting p21 (WAF1/CIP1): A protein that halts division (the "Red Light").
  • Reducing Cyclins A & E: Removing the proteins that drive the cell forward (the "Gas Pedal").
  • Reducing Rb Phosphorylation: Keeping the "Rb" protein in a locked state.

Source: A. hippocastanum, A. chinensis

Mechanism 2: Self-Destruct

Apoptosis & Alternative Death

Target: Leukemia (HL-60, K562), Liver (HepG2)

Compounds force cancer cells to die via controlled pathways:

  • Classic Apoptosis: Marked by DNA fragmentation and Annexin V+ markers (Leukemia).
  • Caspase-Independent Death: A unique "backdoor" cell death pathway observed in liver cancer cells (HepG2), bypassing the usual enzymes.

Source: A. chinensis

Mechanism 3: DNA Sabotage

Topoisomerase I Inhibition

Target: Lung, CNS, Ovarian, Breast

Specific saponins (Aesculiosides) interfere with the TOP1 Enzyme, which manages DNA tension.

  • The Blockade: Saponins bind directly to the free enzyme, preventing it from binding to DNA.
  • The Result: If DNA cannot unwind, the cell cannot replicate and eventually dies.

Source: A. pavia

⚗️ Structure-Activity Relationship (SAR): Why Shape Matters

Not all horse chestnut compounds are equal. Research on A. pavia saponins revealed that the chemical shape determines potency. Specifically, the number of Acyl Groups (chemical attachments at C-21 and C-22) acts like teeth on a key.

Two Acyl Groups
🔑🔑
High Potency
(GI50 0.175–8.71 µM)
Examples: Saponins 94, 96, 98
Active against 59 cell lines.
One Acyl Group
🔑
Reduced Activity
Examples: Aesculiosides IIc, IId
Significantly less effective at inhibiting growth.
No Acyl Groups
🚫
Inactive
Examples: Aesculiosides Ia-e
Without these "teeth," the molecule has almost no effect.
🧪 The Prosapogenin Mystery:
Interestingly, when researchers stripped sugars from these saponins to create prosapogenins, the resulting compounds became stronger cell killers but stopped inhibiting TOP1. This implies that while Saponins attack DNA enzymes, their derivatives likely use a completely different, unknown mechanism to kill cancer cells.
Research Glossary for Beginners
Term Simplified Definition Context in Aesculus Research
In vivo / In vitro In vivo = "In a living body" (e.g., mice).
In vitro = "In glass" (e.g., petri dish).
A. chinensis worked in mice (in vivo); A. pavia was tested in cell cultures (in vitro).
Cytotoxicity The quality of being toxic to cells (cell-killing power). β-escin exhibited cytotoxicity (killed cells) at concentrations of 30 µmol/L.
GI50 / ED50 The dose required to inhibit cell growth by 50%. Lower numbers mean the drug is stronger. Prosapogenins had an ED50 of ~3.0 µg/mL, meaning only a small amount was effective.
Caspase-independent A cell death pathway that skips the usual "executioner" enzymes (caspases). A. chinensis var. wilsonii kills liver cancer cells via this alternative route.
Research Note: The data above is derived from specific studies on isolated chemical constituents. Whole plant preparations may not carry these concentrations. Always consult an oncologist before considering herbal adjuncts for cancer therapy. This was an Google Gemini AI summary of the data from (Shiyou Li et al.,2010)
Click to view cancer research excerpts and notes
	

"Recent studies in vivo and in vitro indicate that aescin (β-escin) has significant antitumor activities. β-escin from A. hippocastanum inhibited chemically induced colon carcino- genesis in rats, and in vitro exhibited cytotoxicity at 30 µmol/L or above concentrations in colon cancer cell lines. β-Escin at 5 µmol/L also inhibited HT-29 colon cancer cell proliferation. β-escin induced cell cycle arrest at G1-S phase in part mediated by induction of p21WAF1/CIP1 and/or associated with reduced levels of Cdk2 and cyclins A and E complex; additionally, there was a lower phosphorylation of Rb [93]." (Shiyou Li et al.,2010)

"β-escin isolated from the seeds of A. chinensis var. chinensis induced apoptosis and caused a significant inhibition of HL-60 human acute myeloid leukemia cell and K562- huamn chronic myeloid leukemia cell proliferation in dose- and time-dependent fasion. Morphological evidence of apoptosis, a significant increase of annexin V+ and PI- cells (early apoptotic) and apoptotic DNA fragmentation, were observed in K562 cells treated with β-escin. Flow cytometry analysis indicated that β-escin induced G1-S arrest and led to a significant accumulation of the sub-G1 population in HL- 60 and K562 cells 94, 95." (Shiyou Li et al.,2010)

"Aescin isolated from the seeds of A. chinensis var. wilsonii at a dose of 2.8 mg/kg had a rather high inhibition ratio (43.5 %) on mice H22 tumor growth in vivo. Aescin could induce significant concentration- and time-dependent inhibition of HepG (2) cell viability and induce cell cycle checkpoint arrest and caspase-independent cell death in HepG (2) cells 96." (Shiyou Li et al.,2010)

"An early investigation showed that two prosapogenins of 21-O-tigloyl-22-O-angeloyl-R1-barrigenol (10) and 21-O- angeloylbarringtogenol-C (18) from the acid hydrolysates of the HCSE of A. hippocastanum exhibited significant in vitro cytotoxicity with ED50 of 3.6 µg/mL and 3.0 µg/mL, respectively, in the human nasopharyngeal carcinoma 9-KB cell culture assay 27." (Shiyou Li et al.,2010)

"More recently, 28 individual saponins (72-99) from the fruits of A. pavia and six prosapogenins produced from these saponins were assayed in vitro for their cytotoxicity and inhibition of DNA topoisomerase I (TOP1) 61, 97
Saponins 94, 96 and 98 with two acyl groups at C-21 and C-22 showed activity with GI50 of 0.175–8.71 µM against most of 59 cell lines tested, which were from nine different human cancers including leukemia, non-small cell lung, colon, central nervous system (CNS), melanoma, ovarian, renal, prostate, and breast tumor cell lines.
Aesculiosides IIc (79) and IId (80) with only one acyl group at C-21 showed less activity while aesculiosides Ia-e (72-76) without acyl group showed no or weak activity 61.
Aesculiosides IIa-k (77- 87), IIIa-f (88-93), IVa (95), IVb (97), IVc (99), saponins 94, 96, 98 and six prosapogenins were also tested for their inhibition of DNA topoisomerase I (TOP1) and their activities against A549, PC-3, HL-60, PANC-1, and MRC cell lines.
Most of the tested saponins and prosapogenins with acyl groups showed cytotoxic activity with different GI50 value.
Sixteen cytotoxic aesculiosides 77-80 and 88-99 inhibited TOP1 catalytic activity by interacting directly with the free enzyme and preventing the formation of the DNA-TOP1 complex. Interestingly, six prosapogenins, including 21-O- angeloylproaescigin (13), 21,22-O-diangeloylprotoaescigenin (16), 21,22-O-diangeloylbarringtogenol-C (20), 21-O-angelyol-22-O-2-methylbutanoyl-R1-barrigenol, 21-O-angelyol- 22-O-2-methylbutanoylprotoaescigenin, and 21-O-angelyol-22-O-2-methylbutanoylbarringtogenol-C prepared from the acid hydrolysates of saponins 78, 96, 98, 95, 97, and 99, respectively, showed no TOP1 inhibitory activity, but had stronger cytotoxicity when compared to the related saponins 97." (Shiyou Li et al.,2010)

"As far as cytotoxicity data are concerned the following observations can be made. Most studies were performed on a relatively narrow range of cell lines, usually from one to five, sometimes up to ten. The most notable exceptions in this respect are the reports, in which isolated compounds were assayed by National Cancer Institute (NCI) in anticancer drug discovery screen. For example, Zhang (Zhang and Li 2007) tested triterpenoid saponins isolated from Aesculus pavia against a panel of 59 cell lines from nine different human cancers such as leukemia, non- small cell lung, colon, CNS, melanoma, ovarian, renal, prostate and breast." (Podolak et al,2010)

"Zhang and Li screened five pre-selected saponins isolated from Aesculus pavia against a panel of 59 cell lines from nine human cancers: leukemia, non- small cell lung, colon, CNS, melanoma, ovarian, renal, prostate and breast. These saponins were polyhydroxyoleanenes with or without acyl groups at C-21 and/or C-22 and a sugar moiety composed of a-L-Araf, b-D-GlcAp, b-D-Galp. From the results obtained with a large array of cancer cell lines it seems that the presence of two acyl groups is important for cytotoxicity as non-acylated saponins showed no or only weak activity (Zhang and Li 2007)." (Podolak et al,2010)

"The fruit of Aesculus hippocastanurn L. (horse chestnuts, Hippocastanaceae) has been used as an herbal remedy for the treatment of mammary indurations and cancer (1). Prior phytochemical studies (2-5) on this plant have yielded a saponin, aescin, which is a mixture of the acylated glycosides of protoaesigenin and barringtogenol-C, with angelic, tiglic, and acetic acids as the acyl groups. As a result ofour continuing searches among medicinal plants for novel, naturally occurring, potential antitumor agents, the acid hydrolyzed product of an n-BuOH extract of the fruits of A. hippocastanurn was found to show significant in vitro cytotoxicity in the 9-KB (human nasopharyngeal car- cinoma) cell culture assay (6). Bioassay-directed fractionation of the foregoing active ex- tract led to the isolation and characterization of two cytotoxic sapogenols, the new hippocaesculin [1, ED50 (KB)=3.6 pg/ml] and the known barringtogenol-C 2 1-angelate 12, ED,, (KB)=3.0 pg-mll. Compound 2 was previously isolated from the leaves of Pittosporum tobira (7); however, its cytotoxicity is revealed for the first time." (konoshima1986)


Phytochemicals

Phytochemical Profile

Categorized Chemical Constituents & Concentrations (PPM)

Saponins & Triterpenoids
AESCINBark, Seed 130000 [DukePhyto]
ESCINBark, Leaf, Seed 22000-125300, Tissue Culture [DukePhyto]
ALPHA-AESCINFruit, Seed [DukePhyto]
BETA-AESCINSeed [DukePhyto]
CRYPTOAESCINSeed [DukePhyto]
CRYPTOAESCIN-ASeed [DukePhyto]
CRYPTOAESCIN-BSeed [DukePhyto]
AESCIGENINSeed [DukePhyto]
PROTOAESCIGENINSeed [DukePhyto]
BARRINGTOGENOL-CSeed [DukePhyto]
BARRINGTOGENOL-DSeed [DukePhyto]
BARRINGTOGENOL-C-21-ANGELATEFruit 4.7 [DukePhyto]
FRIEDELINSeed [DukePhyto]
TARAXEROLSeed Oil, Seed [DukePhyto]
HIPPOAESCULINSeed [DukePhyto]
HIPPOCAESCULINFruit 3.1 [DukePhyto]
HIPPOCASTANINESeed [DukePhyto]
SAPONINSSeed 55000-280000 [DukePhyto]
BETA-AMYRINBark, Seed Oil [DukePhyto]
BUTYROSPERMOLSeed, Seed Oil [DukePhyto]
PARKEOLSeed Oil [DukePhyto]
Flavonoids, Procyanidins & Tannins
QUERCETINBark, Seed [DukePhyto]
QUERCETOLSeed [DukePhyto]
QUERCITRINBark, Leaf, Seed [DukePhyto]
ISOQUERCITRINFlower, Leaf [DukePhyto]
KAEMPFEROLBud, Seed [DukePhyto]
RUTINFlower, Plant [DukePhyto]
EPICATECHINBark [DukePhyto]
(-)-EPICATECHINSeed Coat 816.3-4000, Leaf, Fruit Epidermis [DukePhyto]
PROCYANIDIN-A-1Leaf, Fruit Epidermis [DukePhyto]
PROCYANIDIN-A-2Fruit Epidermis, Seed Coat 510.2-1733.3, Leaf [DukePhyto]
PROCYANIDIN-B-1Leaf, Fruit Epidermis, Seed Coat 240 [DukePhyto]
PROCYANIDIN-B-2Leaf, Seed Coat 612.2-3066.7, Fruit Epidermis [DukePhyto]
AESCULITANNIN (A-G)Seed Coat (Various ppm) [DukePhyto]
CINNAMTANNIN-B-1Seed Coat 408.2 [DukePhyto]
LEUCOCYANIDINBark [DukePhyto]
TANNINFlower, Wood [DukePhyto]
OPCSSeed [DukePhyto]
Coumarins & Glycosides
AESCULETINBark [DukePhyto]
ESCULETINBark, Seed [DukePhyto]
AESCULETOLSeed [DukePhyto]
AESCULINBark 30000, Stem, Seed, Pericarp [DukePhyto]
ESCULINBark 30000, Stem, Seed, Pericarp [DukePhyto]
AESCULOSIDESeed [DukePhyto]
FRAXETINBark [DukePhyto]
FRAXINBark, Stem, Seed, Pericarp [DukePhyto]
SCOPOLETINBark [DukePhyto]
SCOPOLINBark, Pericarp [DukePhyto]
HIPPOCASTANOSIDEPericarp [DukePhyto]
Volatiles (Essential Oil)
1,8-CINEOLFlower Essent. Oil 66000 [DukePhyto]
ALPHA-PINENEFlower Essent. Oil 177000 [DukePhyto]
BETA-PINENEFlower Essent. Oil 122000 [DukePhyto]
CAMPHENEFlower Essent. Oil 83000 [DukePhyto]
LIMONENEFlower Essent. Oil 42000 [DukePhyto]
BETA-CARYOPHYLLENEFlower Essent. Oil 13000 [DukePhyto]
BENZALDEHYDEFlower Essent. Oil 11000 [DukePhyto]
GERANIOLFlower Essent. Oil 4000 [DukePhyto]
3-METHYL-BUTAN-1-ALFlower Essent. Oil 4000 [DukePhyto]
BENZYL-FORMATEFlower Essent. Oil 22000 [DukePhyto]
Lipids, Fatty Acids & Sterols
OLEIC-ACIDSeed 18990 [DukePhyto]
LINOLEIC-ACIDLeaf, Seed 620-6415 [DukePhyto]
PALMITIC-ACIDLeaf, Seed 1245 [DukePhyto]
STEARIC-ACIDLeaf, Seed 1015 [DukePhyto]
MYRISTIC-ACIDLeaf [DukePhyto]
LAURIC-ACIDLeaf [DukePhyto]
CHOLESTEROLBark, Seed [DukePhyto]
BETA-SITOSTEROLBark, Seed, Leaf [DukePhyto]
STIGMASTEROLBark, Seed, Leaf [DukePhyto]
CAMPESTEROLBark, Seed, Leaf [DukePhyto]
ALPHA-SPINASTEROLBark, Seed [DukePhyto]
FATSeed 30000-50000 [DukePhyto]
Carbohydrates, Acids & Others
STARCHSeed 300000-600000 [DukePhyto]
CARBOHYDRATESSeed 740000 [DukePhyto]
SUCROSEBranches [DukePhyto]
GLUCOSESeed [DukePhyto]
STACHYOSESeed [DukePhyto]
ALLANTOINBark, Leaf, Branches [DukePhyto]
URIC-ACIDPlant, Seed [DukePhyto]
ADENINEFlower, Seed [DukePhyto]
ADENOSINEFlower, Seed [DukePhyto]
ASCORBIC-ACIDLeaf 147.2, Seed 24 [DukePhyto]
VITAMIN-K-1Leaf [DukePhyto]
Note: Data sourced from Dr. Duke's Phytochemical and Ethnobotanical Databases. Values represent Parts Per Million (PPM) unless otherwise noted.

Misc Chemicals

Additional Constituents & Trace Compounds (PPM)

Extended Procyanidins & Catechins
CINNAMTANNIN-B-2Seed Coat 132.7 [DukePhyto]
PROCYANIDIN-A-4Seed Coat 204.1 [DukePhyto]
PROCYANIDIN-B-3Leaf, Fruit Epidermis [DukePhyto]
PROCYANIDIN-B-4Leaf [DukePhyto]
PROCYANIDIN-B-5Leaf, Fruit, Seed Coat 40-204.1 [DukePhyto]
PROCYANIDIN-C-1Leaf, Seed Coat 13.3-204.1, Fruit Ep. [DukePhyto]
PROCYANIDIN-D-1Leaf, Fruit Epidermis [DukePhyto]
PROCYANIDIN-D2Leaf, Fruit Epidermis [DukePhyto]
PROCYANIDIN-ELeaf, Fruit Epidermis [DukePhyto]
PROCYANIDIN-GLeaf, Fruit Epidermis [DukePhyto]
PROANTHOCYANIDIN-A-4Seed [DukePhyto]
PROANTHOCYANIDIN-A-6Seed Coat 17.9 [DukePhyto]
PROANTHOCYANIDIN-A-7Seed Coat 12.7 [DukePhyto]
PROANTHOCYANIDIN-POLYMERFruit [DukePhyto]
PROANTHOCYANIN-A-2Fruit [DukePhyto]
EPI-CATECHIN-(4-BETA-6)-EPI-CATECHIN...Fruit Epidermis 46.6 [DukePhyto]
EPI-CATECHIN-(4-BETA-8)-EPI-CATECHIN...Fruit Epidermis 22.6 [DukePhyto]
EPI-CATECHIN-(4-BETA-8,2-BETA-7)-CATECHIN...Fruit Epidermis 30.6 [DukePhyto]
EPI-CATECHIN-(4-BETA-8,2-BETA-7)-EPI-CATECHIN...Fruit Epidermis 118.6 [DukePhyto]
Minor Flavonoids & Anthocyanins
ASTRAGALINFlower [DukePhyto]
CYANIDINLeaf [DukePhyto]
FLAVAZIDELeaf [DukePhyto]
FLAVONESSeed [DukePhyto]
ISOKAEMPFERIDEBud [DukePhyto]
ISORHAMNETINBud [DukePhyto]
JUGLANINPlant [DukePhyto]
KAEMPFEROL-3-RHAMNOFURANOSIDELeaf, Flower [DukePhyto]
KAEMPFEROL-4',7-DIMETHYL-ETHERBud [DukePhyto]
LEUCOANTHOCYANSLeaf [DukePhyto]
LEUCODELPHINIDINBark [DukePhyto]
LUTEOLOLSeed [DukePhyto]
MYRICETINPlant [DukePhyto]
MYRICETIN-3',4',7-TRIMETHYL-ETHERBud, Seed [DukePhyto]
QUERCETIN-3',4',7-TRIMETHYL-ETHERBud [DukePhyto]
QUERCETOSIDESeed [DukePhyto]
RHAMNAZINBud [DukePhyto]
RHAMNETOLSeed [DukePhyto]
RHAMNOCITRINBud, Flower [DukePhyto]
RUTOSIDESeed [DukePhyto]
XANTHORHAMNOSIDESeed [DukePhyto]
Sugars, Amino Acids & Nutrients
1-KESTOSESeed [DukePhyto]
2-KESTOSESeed [DukePhyto]
GALACTOSEPericarp, Seed [DukePhyto]
XYLOSESeed [DukePhyto]
MYO-INOSITOLPericarp [DukePhyto]
QUEBRACHITOLBranches, Leaf [DukePhyto]
(-)-QUERBRACHITOLPericarp [DukePhyto]
2-CARBOXYARABINITOLLeaf 11 [DukePhyto]
CITRIC-ACIDBark [DukePhyto]
ACETIC-ACIDSeed [DukePhyto]
GLUCURONIC-ACIDSeed [DukePhyto]
ANGELIC-ACIDSeed [DukePhyto]
TIGLIC-ACIDSeed [DukePhyto]
PROTEINSeed 80000-110000 [DukePhyto]
AMINO-ACIDSLeaf [DukePhyto]
HISTIDINELeaf [DukePhyto]
L-(+)-LYSINESeed [DukePhyto]
L-(-)-TRYPTOPHANSeed [DukePhyto]
SERINELeaf [DukePhyto]
ASHSeed 14000-30000 [DukePhyto]
WATERSeed 30000-400000 [DukePhyto]
Trace Volatiles & Alcohols
5-HYDROXY-METHYL-FURFURALFlower Essent. Oil 4000 [DukePhyto]
BUTYL-ACETATEFlower Essent. Oil 21000 [DukePhyto]
GAMMA-BUTYROLACTONEFlower Essent. Oil [DukePhyto]
DECAN-1-OLFlower Essent. Oil 82000 [DukePhyto]
DODEC-2-EN-1-OLFlower Essent. Oil 14000 [DukePhyto]
NONAN-1-ALFlower Essent. Oil 23000 [DukePhyto]
TRIDEC-2-EN-1-OLFlower Essent. Oil 34000 [DukePhyto]
Remaining Sterols, Lipids & Others
ALPHA-AMURINSeed Oil [DukePhyto]
ALPHA-CAROTENELeaf [DukePhyto]
PROVITAMIN-DSeed 0.9 [DukePhyto]
PHYTOSTEROLSPlant [DukePhyto]
SITOSTEROLLeaf [DukePhyto]
SPINASTEROLSeed [DukePhyto]
CAMPEST-7-EN-3-BETA-OLSeed [DukePhyto]
PLASTOQUINONE-8Seed [DukePhyto]
QUINONESSeed [DukePhyto]
POLYPRENOLSLeaf [DukePhyto]
TRIACONTANESeed [DukePhyto]
PALMITOLEIC-ACIDLeaf [DukePhyto]
ALPHA-METHYL-BETA-HYDROXYBUTYRIC-ACIDSeed [DukePhyto]
ELEUTHEROSIDE-B-1Stem [DukePhyto]
CHOLINEFlower [DukePhyto]
GUANINEFlower, Seed [DukePhyto]
UREALeaf [DukePhyto]
ALLANTOIC-ACIDLeaf [DukePhyto]
APS-SULFOTRANSFERASELeaf [DukePhyto]
(-)-QUINIC-ACIDPericarp [DukePhyto]

Triterpene Aglycones (Chemotaxonomic Markers)

Base Structures Differentiating Genus Sections

North American Markers
Aglycone / Derivative Primary Source
R1-BarrigenolA. glabra, A. pavia (Shiyou Li et al.,2010)
24-Hydroxy-R1-barrigenolA. pavia, A. californica (Shiyou Li et al.,2010)
21-O-angeloyl-R1-barrigenolA. glabra (Shiyou Li et al.,2010)
22-O-angeloyl-R1-barrigenolA. glabra (Shiyou Li et al.,2010)
21,22-O-diangeloyl-R1-barrigenolA. glabra (Shiyou Li et al.,2010)
Eurasian Markers
Aglycone / Derivative Primary Source
ProtoaescigeninA. hippocastanum, A. indica (Shiyou Li et al.,2010)
Barringtogenol-CA. hippocastanum, A. assamica (Shiyou Li et al.,2010)
AescigeninA. hippocastanum, A. chinensis (Shiyou Li et al.,2010)
Barringtogenol-DA. hippocastanum (Shiyou Li et al.,2010)
16-O-acetylprotoaescigeninA. hippocastanum (Shiyou Li et al.,2010)

Extended Saponin Complex

Specific Isomers & Glycosides from Related Species

Escin & Isoescin Isomers
Compound Source Species
Escin Ia, Ib, IIa, IIbA. hippocastanum, A. turbinata, A. chinensis (Shiyou Li et al.,2010)
Escin IIIa, IIIb, IV, V, VIA. hippocastanum (Shiyou Li et al.,2010)
Isoescin Ia, Ib, VA. hippocastanum, A. turbinata (Shiyou Li et al.,2010)
Deacetylescin Ia, Ib, IIa, IIbA. turbinata (Shiyou Li et al.,2010)
Desacylescin I, IIA. turbinata (Shiyou Li et al.,2010)
Isoescin VIa, VIIa, VIIIaA. turbinata (Shiyou Li et al.,2010)
Aesculiosides & Assamicins
Compound Source Species
Aesculioside A - HA. chinensis (Shiyou Li et al.,2010)
Aesculioside Ia - IeA. pavia (Shiyou Li et al.,2010)
Aesculioside IIa - IIkA. pavia (Shiyou Li et al.,2010)
Aesculioside IIIa - IIIfA. pavia (Shiyou Li et al.,2010)
Aesculioside IVa - IVcA. pavia (Shiyou Li et al.,2010)
Assamicin I - VIIIA. assamica (Shiyou Li et al.,2010)
Aesculiside A, BA. indica, A. chinensis (Shiyou Li et al.,2010)

Minor Constituents & Pigments

Carotenoids, Flavonoids, Coumarins & Acids

Carotenoids (Floral/Pollen)
Compound Source Species
Aesculaxanthin (& isomers)A. hippocastanum, A. pavia (Shiyou Li et al.,2010)
Capsanthin (& 5,6-epoxide)A. turbinata, A. pavia (Shiyou Li et al.,2010)
CapsorubinA. turbinata, A. pavia (Shiyou Li et al.,2010)
Neolutein CA. hippocastanum (Shiyou Li et al.,2010)
Violaxanthin (& 9-cis)A. hippocastanum (Shiyou Li et al.,2010)
Beta-CryptoxanthinA. hippocastanum (Shiyou Li et al.,2010)
Beta-CitraurinA. hippocastanum (Shiyou Li et al.,2010)
NeochromeA. hippocastanum (Shiyou Li et al.,2010)
Coumarins, Flavonoids & Acids
Compound Source Species
UmbelliferoneA. hippocastanum (Shiyou Li et al.,2010)
ChikhorinA. hippocastanum (Shiyou Li et al.,2010)
Multinoside AA. hippocastanum (Shiyou Li et al.,2010)
Multiflorin BA. hippocastanum, A. chinensis (Shiyou Li et al.,2010)
Aescuflavoside (& A)A. chinensis (Shiyou Li et al.,2010)
PavietinA. pavia (Leaf) (Shiyou Li et al.,2010)
DistichinA. pavia (Shiyou Li et al.,2010)
TrifolinA. chinensis (Shiyou Li et al.,2010)
Tianshic AcidA. chinensis (Shiyou Li et al.,2010)
Wilsonic AcidA. chinensis (Shiyou Li et al.,2010)
Cyclopropane amino acidsA. parviflora (Shiyou Li et al.,2010)

Bark:

"The bark of Aesculus hippocastanum, in common with the seeds, has been described as containing the saponin mixture ‘escin’ 3. Coumarin glycosides, including esculin, scopolin and fraxin, and their respective aglycones, esculetin, scopoletin and fraxetin, are also present in the bark of A. hippocastanum (Figure 4), in contrast to seed tissues, in which these compounds have not been detected. The flavonoid glycoside quercitrin (Figure 2), and its corresponding aglycone have also been detected in bark tissues. Additional compounds, including allantoin, sterols, leucocyanidin, leucodelphinidin, catechol tannins and alkanes have also been described as occurring in bark tissues. 3" (wilkinson1999)

Leaves:

"In common with the bark of A. hippocastanum, leaf tissues contain the coumarin glycosides scopolin, fraxin and esculin (Figure 4) [3]. A range of flavonoid glycosides of quercetin (e.g. quercitrin, rutin, isoquercitrin and quercetin 3-arabinoside) and the corresponding glycosides of kaemperfol have also been detected in leaf tissues (Figure 2). In addition to these glycosides, escin has been detected (but only in trace amounts), as well as leucanthocyans, cis,trans-polyprenols, amino acids, fatty acids and sterols (sitosterol, stigmasterol and campesterol)." (wilkinson1999)

  • Triterpene saponins [PDR]
  • Hydroxycoumarins: "chief component is aesculin, in addition fraxin and scopolin" [PDR]
  • Flavonoids: "including rutin, quercitrin, and isoquercitrin" [PDR]
  • Tannins [PDR]

"Twenty-one carotenoids have been identified from Aes- culus. An early investigation on the leaves and pollen of the three species A. turbinata, A. pavia, and A. parviflora by HPLC analysis indicated the presence of seven carotenoids β-carotene (162), zeaxanthin (163), α-carotene (167), lutein (168), capsanthin (176), capsanthin 5,6-epoxide (177), and capsorubin (178) [74]. A high concentration of α-carotene was found in the leaves and keto hydroxyl carotenoids with a pentanuclear ring structure (capsanthin, capsanthin 5,6- epoxide, and capsorubin) were identified in the pollen. These keto hydroxyl carotenoids were proposed to have special chemotaxonomic significance for the genus Aesculus. Later, in 2000, 16 carotene derivatives were detected in buds, pol- len, and petals of A. hippocastanum and A. pavia by HPLC analysis with a diode array detector utilizing authentic sam- ples as the references. These carotenoids are β-carotene (162), β-cryptoxanthin (164), violaxanthin (165), 9-cis-violaxanthin (166), lutein (168), 13-cis-13'-cis-lutein (169), lutein 5, 6-epoxide (170), neolutein C (171), β-citraurin (172), aesculaxanthin (173), 9-cis-aesculaxanthin (174), 13-cis-aes- culaxanthin (175), 9'-cis-neoxanthin (179), 9-cis-9'-cis-neox- anthin (180), neochrome (181), and luteoxanthin (182) [75]." (Shiyou Li et al.,2010)

Seed Phytochemicals

"Horse-chestnut seeds, as all others seeds, are natural products whose chemical composition is a very complex matrix. They contain a lot of different molecules and analytes, the majority of which are polysaccharides (both starches and non-starches), proteins, lipids, mineral salts and many minor components among others, with homogeneous or localised distributions in different districts, all strongly interacting with each other in a synergistic way to form very complex structures." (baraldi2007)

"A number of other products have been isolated from chestnut seeds, i.e., coumarin derivatives (aesculin, fraxin, scopolin), essential oils (oleic acid, linoleic acid), and tanins (leucocyanidine, proanthocyanidin A2) (4)." (kapusta2007)

"It is interesting that different organs of this species contain distinctive classes of the main bioactive principle: aescin in the seeds, essential oils in the leaves, and flowers and coumarins in the bark." (kapusta2007)

"For completeness, our experimental data about the com- position of common Mediterranean horse-chestnuts, can be compared with some literature values reported by Par- mar and Kaushal (1982), even though they worked with Aesculus indica seeds from fresh fruits. Aesculus indica is a very common botanical species and largely diffused in Himalayan forests, also pertaining to Hippocastanaceae family, with some distinctive features and characters from each others.
Probably, this comparison can result in a limited useful- ness because of different uses of AHP or AHH and Aescu- lus indica seeds, being the latter foodstuff still largely consumed by local populations of Himachal Pradesh region. Starch of seeds (about 40% on fresh fruits, with a ratio amylopectin:amylose =/~3:1) was recommended as famine food for extending bread flour (or other uses), after removal of bitter characters." (baraldi2007)

  • "...powdered hydroalcoholic extracts of the seeds contain 16 to 20 percent triterpene glycosides (a class of saponins), calculated as aescin (escin). Aescin... is believed to be the main active constituent of horse chestnut seed extract (Schulz, Hänsel, and Tyler, 2001)." [Barrett HCTHR]
  • "Triterpene saponins (3-5%): The triterpene saponine mixture known as aescin (also escin) consists of diacylated tetra-and pentahydroxy-beta-amyrin compounds...." [PDR]
  • Flavonoids: "in particular biosides and triosides of the quercetins" [PDR]
  • Oligosaccharides: "including 1-kestose, 2-kestose, stachyose" [PDR]
  • Polysaccharides: "starch (50%)
  • Oligomeric proanthocyanidins, condensed tannins: (only in the seed-coat)" [PDR]
  • Fatty oil (2-3%) [PDR]

"Seeds of A. hippocastanum have also been described as containing starch (40–50% weight) [6], sugars, proteins (specifically the globulin, hippocastanine, containing L-(1)lysine and L-(1)-tryptophan), a fatty oil (containing oleic, linoleic, linolenic, stearic and palmitic acids) and purines (adenosine, adenine and guanine). [5]" (wilkinson1999)

"The saponins present in these seeds render them very bitter, disagreable and unedible for humans. On the con- trary, they can be consumed for human uses after removing the bitterness of grounded flour, by soaking it in water for about 12 h. The bitter components get dissolved in water and removed when the water is decanted. The remaining slurry can be destined for cuisine manipulations, and is generally taken as a non-cereal-starch food. As reported by Parmar and Kaushal (1982), the Aesculus indica seeds, which constitute the edible portion of the fresh fruits, con- tain about 50.5% moisture. The total sugars content is 5.58% (11.0% on dry matter basis), combining the reducing (4.59%) and non-reducing sugars (0.94%), respectively. The protein and mineral contents are 0.388% and 1.934%, respectively, on fresh samples, that become 0.768% (pro- teins) and 3.83% (minerals) on dry samples. Therefore, we can assert that Aesculus indica seeds are less proteinic and less glucidic with respect to AHP and AHH seeds sam- ples here tested." (baraldi2007)

"Coumarins isolated from Aesculus usually have simple structures." (Shiyou Li et al.,2010)

"The seeds of Aesculus also contain a number of long fatty chain compounds." (Shiyou Li et al.,2010)

Aescin (Seeds)

"The principal extract and medicinal constituent of Aesculus hippocastanum (horse chestnut) seed is aescin, a mixture of triterpenoid saponin glycosides. It can be fractionated into beta-aescin, an easily crystallizable mixture, and alpha-aescin, which is water-soluble." [HPEP]

"The total saponin content of seeds, often expressed as ‘(a)escin’ (Figure 1), actually consists of α-escin and β-escin, the latter of which is, in turn, composed of more than 30 derivatives of the triterpenoids, protoaescigenin and barringtogenol C. These compounds are primarily found in the seed cotyledons (they can constitute up to 28% of the weight of the dry seeds), but have also been detected in the seed integument, the bark, buds, leaves and the immature fruit pericarp of A. hippocastanum [5]." (wilkinson1999)

"Aescin is fairly soluble in water but is poorly soluble in lipid solvents." [Schulz RP]

"CAN cautions that aescin is nephrotoxic. Side effects include GI disturbance, impaired liver function, mild nausea, shock, spasm, urticaria, and vomiting. Should be avoided by patients on blood-thinning therapy, with hepatic or renal impairment, or lactating or pregnant. Large doses of saponins can be fatally hemolytic in animals. LD50s range for aescin from 134 to 720 orally in mice, rats, and guinea pigs. On ipr administration, the total saponin fraction (LD50 = 46.5 mg/kg ipr mouse) was less toxic compared to isolated aescin (LD50 = 9.5 mg/kg ipr mouse) (CAN). LD50 of seed extract 990 mg/kg orl mouse, 2150 orl rat, 1530 orl rbt, 130 orl dog."[HMH Duke]

Flavonoids (Seeds)

"Flavonoids and their derivatives are also one of the main components of the genus Aesculus. A total of 49 flavonoids including flavonols and their glycosides (100-126), flavanones, and flavanone derivatives (127-148) were iso- lated and identified from the seeds of Aesculus." (Shiyou Li et al.,2010)

"In the present work, the main flavonoids from horse chestnut seeds were isolated and their structures established with spectral methods. Seven glycosides were isolated, out of which six (2, 3, 4, 7, 11, 13) were previously reported and one (9) was identified as a new tamarixetin 3-O-[β-D-glucopyranosyl(13)]-O-α -D-xylopyranosyl-(12)-O-β-D-glucopyranoside." (kapusta2007)

"Thirteen compounds could be identified in the profile, out of which di- and triglycoisdes of quercetin and kaempferol were the dominant forms and their acylated forms occurred in just trace amounts. The total concentration of flavonoids in the powdered horse chestnut seed was 0.88% of dry matter. The alcohol extract contained 3.46%, and after purification on C18 solid phase, this concentration increased to 9.40% of dry matter. The flavonoid profile and their content were also measured in the horse chestnut wastewater obtained as byproduct in industrial processing of horse chestnut seeds. The total flavonoid concentration in the powder obtained after evaporation of water was 2.58%, while after purification on solid phase, this increased to 11.23% dry matter. It was concluded that flavonoids are present in a horse chestnut extract in a relatively high amount and have the potential to contribute to the overall activity of these extracts. Industrial horse chestnut wastewater can be used to obtain quercetine and kaempferol glycosides for cosmetic, nutraceutical, and food supplement industries." (kapusta2007)

"In the present research, we also studied the flavonoid profile and concentration in the powder obtained after evaporation of water from horse chestnut wastewater (WWHC). The large volume of WWHC remains in the process of precipitation of aescin from the horse chestnut extracts. This is waste byproduct still containing some amount of saponins and flavonoids, which can be commercially useful." (kapusta2007)

"The flavonoid profile of WWHC was identical to the profile of HCE, with the total concentration of 2.54% dry matter. One-step purification of this fraction on the solid phase produced WWHCF, the product with flavonoid concentration of 11.23% dry matter. This has been a quite high amount, and the product can have commercial value. It can be used in the pharmaceutic, cosmetic, and food industries. Eleven percent concentration of flavonoids makes the product an attractive source for the nutraceutic industry as a high-flavonoid supplement. As shown above, horse chestnut flavonoids are the mixture of quercetin and kaempferol glycosides, the most desired flavonoids in our diet due to their antioxidant activity. Quercetin and kaempferol were documented to be the most potent antioxidant of all flavonoids, (10) and their daily consumption is estimated to be about 25 mg per day (11). Further increase of this amount in the diet can be obtained by flavonoid supplementation, and WWHCF can be a good source of this. The economic evaluation of this source should be performed. It seems logical that the WWHC, instead of being dried and powdered, can be simply passed through a solid-phase column (reversed-phase C18 or Amberlite XAD4), which retains flavonoids and lets saccharides and other strongly polar components of the WWHC matrix go through." (kapusta2007)

"It can be concluded that the flavonoid content in horse chestnut seed seems to be high enough to contribute to overall activity of the extracts. The high content of flavonoids in industrial horse chestnut wastewater and the ease of their condensation and purification makes this byproduct a promising source of quercetin and kaempferol glycosides to be used in the cosmetic and food additive-producing industries." (kapusta2007)

"Nine flavonol oligosides of quercetin and kaempferol with glucose, xylose, and rhamnose as sugars were isolated from the seeds of Aesculus hippocastanum L. (Hippocastanaceae). Five of them are new compounds (2 trisaccharides, 1 bisdesmoside, a nicotinic and a indolinone hydroxyacetic acid ester of the bisdesmoside)." (Hubner,1999)

"Extracts of the seeds of Aesculus hippocastanum L. (horse chestnut; Hippocastanaceae) are widely used to successfully treat chronic venous insufficiency (1), (2). The main active constituent is considered to be aescin, a mixture of several saponin esters of the oleanane type (1), (3). However, some authors believe that the flavonoids contribute to the observed activity of horse chestnut seed extracts (3), (4)." (Hubner,1999)

"The partial lack of knowledge about the polyphenolic fraction of this widely used crude drug has led to the following re-examination of the flavonoids of the seeds of A. hippocastanum." (Hubner,1999)

"A quantitative determination of the flavonoids according to Betulae folium of the European Pharmacopoeia (1997) gave a total flavonoid content of 0.29% (calculated as rutin)." (Hubner,1999)

"In conclusion, the seeds of A. hippocastanum contain a series of quercetin and kaempferol di- and triglycosides, some of which have unusual acyl substituents. The overall content of ca. 0.3% (calculated as rutin) is low. Hence, a contribution of the flavonol glycosides to the therapeutic efficacy of the crude drug seems unlikely." (Hubner,1999)

Sugars (Seeds)

"The values obtained for total glucides content in these natural products was in the range 14.3% (AHH)–15.2% (AHP). As previously mentioned in the experimental sec- tion, our analysis methodology permit us to determine the two most important monosaccharides (and appar- ently, the only species in these matrices), such as glucose and fructose. However, we observe that while glucose concentration is almost the same on the two sample groups (6.8% for AHP and 6.9% for AHH), fructose con- tent is well differentiated (8.4% for AHP and 7.4% for AHH).
Actually, we are unable do determine the presence of other sugars, such as the most common sucrose (the disac- charide based on glucose and fructose condensation). Nev- ertheless, we are obliged to mention that, generally, edible chestnut seeds mainly contain sucrose (about 10–30%), and only few traces of free monosaccharides (about 0.1–0.5%) (De La Montana Miguelez et al., 2004)." (baraldi2007)

Fatty Acids (Seeds)

"Therefore, the aims of this work were to study some characters of chemical composition and the relevant classi- fication of seeds from two most wide spread varieties of Aesculus hippocastanum L., such as pure species, with white flowers (AHP), and a common hybrid species with pink flowers (AHH). Both these common Hippocastanum trees are growing in the mediterranean regions, and their luxuri- ous summer flowering is very showy." (baraldi2007)

"Lipids represent a significant fraction on these original products (4–5% of the dry mass)" (baraldi2007)

(baraldi2007)

Epicuticular Leaf Waxes

"Ae. hippocastanum leaves (102 g) contained an extractable epicuticular wax (241 mg) of about 0.63% dry wt., which calculated for 22 µg wax per cm2 leaf surface area or 4540 µg wax per one leaf. This wax of mature leaves consisted, like the wax of C. sativa (Castanea sativa), of homologous series of wax lipids and in addition greater amounts of triterpenoids (54% of the wax). Main lipid classes are aldehydes (13%), fatty acids (8 %), primary alcohols (7%), wax esters (7%), hydrocarbons (5%) and addi­tionally acetates (5%). Composition and yield of the individual lipid classes are listed in Table I. The compositions of the homologous series are sum­marized in Table II.
All these lipid classes have the same chain lengths as found for C. sativa and show no main component dominating. The distribution patterns of these lipids are therefore very even.
Triterpenols were found to be the dominating wax compounds. ß-Amyrin, a-amyrin and lupeol were again predominant in a relative ratio of 3:2.2:2.2. These triterpenols were present also esterified with fatty acids (2% of the wax). Fur­thermore, friedelanol and friedelanone were iden­tified by GC-MS and comparison with authentic samples [6 , 7]. The latters were found in concentra­ tions of about 1.5% of the wax, each...." (P.-G. Gülz et al.)

"The SEM figures of mature leaves of Ae. hippo­castanum show no trichomes on the abaxial as well as on the adaxial epidermis. Both leaf surfaces are characterized by numerous cuticular lamellae (Fig. 2, A and B). The cuticular lamellae are found to be linear (Fig. 2,C) and also wavelike (Fig. 2, D). All epidermal cells are covered with a continuous wax layer without any wax sculptures or crystalloids. After washing the leaves with chlo­roform all wax was extracted. The remaining cuti­ cular lamellae are clearly visible on the abaxial and adaxial epidermal cells...." (P.-G. Gülz et al.)

"C. sativa and Ae. hippocastanum are systemati­ cally not very closely related plant genera. How­ever, they have a rather similar wax composition. They contain the same homologous series of wax lipids, but with individual distribution patterns. No one of these lipid classes has one main compo­nent dominating. In addition to the wax lipids, both plant waxes contain mixtures of triterpenols. In C. sativa wax ß-amyrin, a-amyrin and lupeol are found. In Ae. hippocastanum wax the same tri­terpenols are analyzed and additionally friedelanol and friedelanone. Both leaf waxes contain wax lipids and triterpenols with no main component in a dominating concentration. Therefore, wax crys­talloids on the leaf surfaces of these two plants are not expected." (P.-G. Gülz et al.)


Folkore

"The common name "horse chestnut″ may have come from the uses of seeds for horses to treat overexertion or coughs by Turks and Greeks [18]. Dated from the early 18th century, the horse chestnut has a therapeutic property for anti-fever [5]. In Europe, the bark and leaves of A. hippocastanum have been employed as an astringent to treat diarrhea and hemor- rhoids [6]." (Shiyou Li et al.,2010)

  • The drug is generally provided by the ripe seed, as described in German and Spanish pharmacopeias, while Portuguese pharmacopeia also includes the bark. [Bajaj MAPS 7]
  • Some kind of horse chestnut decoction was drunk in Essex for lumbago, spoken of there as rheumatism (Newman & Wilson)." [DPL Watts]
  • "Elsewhere, including Spain (H W Howes), it is piles that is reckoned to be cured or prevented by carrying them around (W B Johnson; Tongue; Fogel), and that is interesting, because it is known that extracts of horse chestnut are rich in Vitamin K, and so is useful in treating circulatory disorders like piles, varicose veins and chilblains (Conway)." [DPL Watts]
  • "A fluid extract made from the nuts is also used to protect the skin from the harmful effects of the sun (Schauenberg & Paris)." [DPL Watts]
  • "Another usage of conkers was as a snuff to cure catarrh and headache. The Pennsylvania Germans used it that way (Fogel), but this was quite an early habit (see Thornton), and the idea was to grate them up and use the powder to make one sneeze. Apparently it was recommended not only as a powder but also as an infusion or decoction to take up the nostrils. The leaves and flowers have occasionally been used, too (and so has the bark)." [DPL Watts]
  • "The leaves are narcotic; an infusion of them has been used for insomnia(Conway)" [DPL Watts]
  • "A tincture of the flowers is sometimes given for rheumatism (Perry. 1972)." [DPL Watts]
  • "The bark has been used for fevers, and externally, for ulcers (Wickham)" [DPL Watts]
  • Several French works published between 1896 and 1909 reported successful outcomes in the treatment of hemorrhoidal ailments. [Schulz RP]

"The bark is no longer in common use, but has a folk medicinal application as a febrifuge, and as an astringent in cases of diarrhoea and haemorrhoids [4]. Decoctions of the bark are also used, albeit rarely, for the topical treatment of skin disorders, such as sores, lupus and ulcers [4]. The bark has also previously been used as an anti-malarial agent, as a cinchona substitute, but this practice is no longer continued [3]. Horse chestnut leaf preparations are used in folk medicine to treat coughs, rheumatism and arthritis, although the underlying phytochemical basis for these applications has not been determined [3]." (wilkinson1999)


Cultivation

"Prefers a deep loamy well-drained soil but is not too fussy tolerating poorer drier soils[11, 200]. Tolerates exposed positions and atmospheric pollution[200]. A very ornamental and fast-growing tree[1, 4], it succeeds in most areas of Britain but grows best in eastern and south-eastern England[200]. Trees are very hardy when dormant, but the young growth in spring can be damaged by late frosts. The flowers have a delicate honey-like perfume[245]. Trees are tolerant of drastic cutting back and can be severely lopped[200]. They are prone to suddenly losing old heavy branches[98]. The tree comes into bearing within 20 years from seed[98]. Most members of this genus transplant easily, even when fairly large[11]. Special Features: Attractive foliage, Not North American native, Naturalizing, Blooms are very showy."[PFAF]

"Presowing treatment of seeds with cobalt nitrate increased drought resistance of horse chestnut (Aesculus hippocastanum L.) from the Donets Basin in southeastern Europe (87)." [Barker HPN]

"In conclusion, our results suggests that in horse-chestnut, where natural variation is large and vegetative propagation through natural cross-hybridisation and grafting is very easy, the traditional method of selection variety may give good results in terms of selected fruits and seeds productions, also in relation to the optimisation procedures for technological transferability, and to obtain the best performances for bio-available supplements and specific salutary targets." (baraldi2007)

A single exotic pathogen that has appeared in Europe in the last decade, has devastated the European horse chestnut (Aesculus hippocastanum). "Trees were observed to be suffering from a new form of bleeding canker on their stems which ultimately kills them, firstly in continental Europe and more recently across the UK as well. The causal agent of the disease was identified as a new species of pathogenic bacterium; Pseudomonas syringae pv. aesculi. It is thought that this bacterium originated in India on the Indian horse chestnut, and was probably introduced to Europe via the plant trade (as highlighted by Brasier 2008).... results have shown that there is only one strain of this organism across the whole of Europe, which suggests that the outbreak is probably the result of a single introduction event." [Fenning COWF]

"...A. hippocastanum could be suggested as an appropriate biomonitor for Pb atmospheric pollution, and for Cu in highly polluted areas." [Anicic, 2011]

Propagation

"Seed - best sown outdoors or in a cold frame as soon as it is ripe[11, 80]. The seed germinates almost immediately and must be given protection from severe weather[130]. The seed has a very limited viability and must not be allowed to dry out. Stored seed should be soaked for 24 hours prior to sowing and even after this may still not be viable[80, 113]. It is best to sow the seed with its 'scar' downwards[130]. If sowing the seed in a cold frame, pot up the seedlings in early spring and plant them out into their permanent positions in the summer."[PFAF]

"Propagation is generally by seed, which fall in autumn, remain dormant over winter, and germinate in spring, at least in Liguria (Italy). In the first year plants have either two or four leaves. The vegetative growth of such plants returns the following year. The plant may also be propagated by cutting; in this case the specimens have the same morphological and physiological characteristics as the parent plant." [Bajaj MAPS 7]

Bioaccumulation

"The mean concentrations of heavy metals (Pb, Cd, Zn and Cu) in the unwashed and washed leaves, bark and soils of A. hippocastanum from different sites are presented.... A comparison of concentrations of heavy metals in the leaves, barks and soils reveals that the values in the urban roadside are higher than other sites due to higher human activity and higher vehicular traffic. A similar finding is reported by Tam et al. (1987) from Hongkong who found a significant correlation between traffic density and Pb, Cu and Zn concentrations. The heavy metal concentration in the bark and soils are higher than in the leaves as in our findings." (Yilmaz,2006)

"The highest lead concentration was found in the urban roadside soils (6.745 µg g-1) as compared to the suburban soils (0.812 µg g-1)....In the A. hippocastanum leaves the highest values of lead in the urban roadside samples (0.119 µg g-1),....Lead concentration of the bark too as expected was high in the urbanroadside samples (0.628 µg g-1)," (Yilmaz,2006)

"The Cd values in our samples in general are very low, but highest values were recorded in the urban roadside unwashed samples (0.068 µg g-1). The values for unpolluted natural environments should lie between 0.01-0.03 µg g-1 (Allen, 1989)....The reason for the low values could be due to a low atmospheric deposition in this region because of long lasting rainy season." (Yilmaz,2006)

"In A. hippocastanum the Zn concentrations measured during this study were between 0.374 - 0.532 in the washed leaves, 0.391-0.591 in the unwashed leaves, 0.406- 0.660 in the bark and 2.196 and 4.598 µg g-1 in soil....By following the Zn pollution criteria levels of Dmuchowski and Bytnerowicz (1995), we can conclude that Thrace region does not show Zn pollution....In the uncontaminated soils, the total Zn content is said to lie between 10-300 µg g-1 (Freedman & Hutchinson, 1981). In these soils, total Zn is constant in the soil profile, but extractable Zn generally decreases with depth because of decrease in organic matter. The higher amount of the Zn in our soils can be attributed to the high organic matter content." (Yilmaz,2006)

"The soil Cu can vary greatly among the sites at the same location and in different locations. The Cu values of soil samples supporting A. hippocastanum lie between 0.5171 and 1.1165 µg g-1,in the unwashed leaves Cu content ranges between 0.322-0.466, in the washed leaves between 0.256 and 0.387 and in the bark between 0.3451-0.117 µg g-1. In normal uncontaminated soils Cu content varies between 2-100 µg g-1 (Freedman & Hutchinson, 1981). Our values are low."

"Washing the leaves significantly reduced the lead, cadmium, zinc and copper concentrations. The reduction for the lead was 57.14 percent for the urban roadside, 27.66 for the city centre and 13.04 for the suburban area, whereas for cadmium these values were 97.06, 50.0 and 0.0 % respectively. In the case of zinc the reduction was 10.43 % in the urban roadside, 3.36 % in the city centre and 4.35 % in the suburban areas, and for copper it was 16.95 % in the urban roadside, 17.39 % in the city centre and 20.50 % in the suburban areas. The percentage removal was the highest in the urban roadside (57.14 %) as compared to suburban. The reason for this is differences in the atmospheric deposition of these metals and high and low traffic densities. This data coincides with that of Al-Shayeb et al. (1995) who reported a removal of 26-68 % of Pb by washing." (Yilmaz,2006)

"The atmospheric deposition of heavy metals in the present study area is not very high, the concentration of heavy metals in A. hippocastanum did not exceed the upper limit." (Yilmaz,2006)

"The regression analysis data shows (Fig. 6) that our values for soils and plants are significant for Pb, Zn and Cu, but not for Cd. We can thus conclude that with an increase in the amount of the heavy metals in the soil, their uptake by plants also increased." (Yilmaz,2006)

"A. hippocastanum is widely distributed in Europe and is used as a roadside ornamental tree. In accordance with the data presented here this tree possesses all the characteristics for its selection as a biomonitor." (Yilmaz,2006)

"This study gives an evidence for the seasonal accumulation of Cr, Fe, Ni, Zn, and Pb in leaves of A. hippocastanum and Tilia spp. (except Zn) sampled in the Belgrade urban area. During the studied time span, Pb concentrations in the leaves showed a decreasing trend (more regular for A. hippocastanum), being in accordance to the bulk atmospheric deposition data. Also, the temporal concen- tration trend for the Cu in A. hippocastanum was decreasing and in accordance with the Cu trends in the bulk atmospheric deposition at the site with the highest atmospheric Cu loading. No agreement was observed between the accumulation trend of Cr, Fe, Ni, and Zn in leaves and the bulk deposition rates, i.e. the elements content in the leaves did not reflect atmospheric deposition directly.
Accordingly, A. hippocastanum could be suggested as an appropriate biomonitor for Pb atmospheric pollution, and for Cu in highly polluted areas." (Anicic,2011)

"The concentrations of cadmium, copper, lead and zinc have been measured in the leaves of a deciduous tree the horse chestnut (Aesculus hippocastanum L.) over the period of their lifetime (7 months). The average concen- trations for the total sample based on ash weight are." (txg g l) cadmium, 0.197; copper, 129; lead, 294; and zinc, 299. The temporal trends in the concentrations of the metals can be related to their dominant source. Cop- per and zinc concentrations are highest in the new leaves and decrease with time, suggesting the main source of the elements are uptake from the soil. The decrease occurs partly because of dilution by leaf material as it increases over the growing period. In the case of zinc, however, aerial deposits appear to be also a significant source. Lead concentrations, on the other hand, show an increase with time, which can be related to increasing deposits from aerosol lead arising from the combustion of petrol lead. The increase is enough to offset the dilution effect. For cadmium there is no significant trend, but the ten- dency is a decrease with time. It is not possible, however, to distinguish between soil uptake and aerial deposit as both are small compared with increase in leaf material." (kim1994)

"The measure of the maturity of the leaves in terms of the amount of internal consolidation ( g c m 2) is lowest in samples collected when the leaves first opened, and increases steadily until January-March. Ash weight concentrations of copper and zinc show the opposite trends, and decrease (in a non-linear manner) with the age of the leaves. Highly significant negative correla- tions between the variable ( g c m -2 x 105) and the con- centrations of copper and zinc suggest that growth of the leaves causes dilution in the concentrations of cop- per and zinc, but also there may be some loss of the metal ions out of the leaves. Growth of the leaves may account for about 60--70% of the reduction in copper and zinc concentrations with time." (kim1994)

"The fact that copper and zinc concentrations are highest when the leaves first open implies that these metals are primarily derived from the soil and that most of the copper and zinc is translocated into the leaves prior to their unfolding. In the case of zinc, how- ever, as the leaves grow an atmospheric contribution becomes important, offsetting to some extent the dilu- tion due to leaf growth. The association of copper and zinc with developing leaves is probably a result of the roles that these two metals have in plant protein and carbohydrate metabolism." (kim1994)

"Ash weight lead concentrations are lowest when the leaves first appear, and increase in a linear (and highly significant) manner with the age of the leaves. The source of this lead is likely to be petrol combustion, and it is probable that direct deposition of the lead-rich aerosols on the leaves (rather than translocation of lead from the roots) is the predominant enrichment path- way. The rate of lead accumulation is sufficient to negate any dilution effect that might be caused by leaf growth." (kim1994)

"No clear (statistically justified) trend is evident which links cadmium concentrations in horse chestnut leaves with the age of the leaves. Additionally, cadmium con- centrations in the leaves are uncorrelated with those of copper, lead or zinc. However, a 'very significant' nega- tive correlation between cadmium concentrations and the variable (g cm 2 x 10 5) suggests that growth of the leaves may cause some dilution in cadmium concentra- tions. It is possible that, if cadmium is accumulating on/in the leaves, the rate of this accumulation is suffi- cient to partially compensate for the dilution effect caused by the leaves growing. Unlike the results for copper, lead and zinc, the results for cadmium do not clearly identify probable sources or enrichment path- ways of that metal to leaves." (kim1994)

"Leaves collected from the three sites situated near main roads (sites 1, 4 and 5) have statistically more cadmium, copper, and lead than leaves collected from the other sites, implying that traffic is a source of cad- mium, copper and lead to horse chestnut leaves. The atmospheric source of zinc may derive from weathering of galvanised iron roofs, which are relatively common in New Zealand." (kim1994)


AESCULUS BUCKEYE

"Large shrub or tree. Leaf: palmate, leaflets 5–7[9]. Flower: petals 4[5], >> sepals. Fruit: capsule leathery. Seed: 1, large.
± 15 species: northern hemisphere. (Latin name for a sp. of oak)" [Jepson]

Local Species;

  1. Aesculus hippocastanum - Horse-chestnut [Cultivated]

"Aesculus L. is a genus of the family Hippocastanaceae containing 12 species of deciduous trees and shrubs in the northern hemisphere, primarily in eastern Asia and eastern North America, with one species native to Europe, and two to western North America [1-4]." (Shiyou Li et al.,2010)

"Aesculus hippocastanum has been cultivated since 1576 as an ornamental plant [17] while A. chinensis var. chinensis has been planted in temples and homes for several centuries. At present, all species are cultivated, with at least 27 commercial cultivars supplied by at least 95 nurseries in the United States [17]." (Shiyou Li et al.,2010)

"There are two Eurasian species commonly used in medicine: A. hippocastanum (common horse chestnut) and A. chinensis var. chinensis (Chinese horse chestnut)." (Shiyou Li et al.,2010)

"To date, over a hundred species or varieties in Aesculus have been described because of great morphological variations due to natural pollination among the species. In his monograph of Aesculus, Koch (1857) recognized 13 species in four subgenera, Hippocastanum, Pavia, Calothyrsus, and Macrothyrsus [12]. Based on bud viscidity, fruit exocarp ornamentation, flower color, and petal morphology, the 13 species were grouped into five sections [1, 2, 13]. All new species discovered in the last several decades are not recognized and thus most authors recognized 13 species in the genus until A. wilsonii Rehder was recently treated as a variety under the species A. chinensis Bunge [3, 14]. The 12 currently recognized species in the genus Asculus are grouped in the five sections...." (Shiyou Li et al.,2010)

Chemotaxonomy

"....Some chemotaxonomical analysis has been conducted [15]. Interestingly, A. pavia in the Section Pavia has tritepernoid saponins with an oligosaccharide chain at C-3 of the aglycone with an α-arabinofuranosyl unit affixed to C-3 of the glucuronic acid while Eurasian species in Section Aesculus and Section Calothyrsus have saponins with a trisaccharide chain at C-3 of the aglycone with a β-glucopyranosyl unit attached to C-4 of the glucuronic acid [16] (see Triterpenoid Saponins for details). This significant chemical difference suggests that triterpenoid saponins may provide important clues in understanding the systematics and evolution of the genus Aesculus." (Shiyou Li et al.,2010)

Use of Related Sp.

"Seeds of North American species (e.g., A. pavia, A. flava, A. glabra, and A. californica), known as buckeyes, were used by Native Americans to tranquilize fish to make them easier to catch [22]. Extracts from the seeds were used to treat earaches, sores, colic, sprains, and chest pains [23]. Powdered bark was sometimes used to alleviate toothaches and ulcer pain [24]." (Shiyou Li et al.,2010)

"The genus Aesculus has 12 species, but only A. hippocas- tanum and A. chinensis var. chinensis, two Eurasian species, are officially recognized sources of herbal products in tradi- tional medicine. HCSE or aescin from A. hippocastanum has shown satisfactory evidence for clinically significant activity in chronic venous insufficiency, hemorrhoids, and post- operative oedema, largely due to its anti-inflammatory prop- erties, which were well demonstrated by in vitro and in vivo assay. However, the mechanism of action of the Chinese horse chestnut is poorly understood and further investigation is necessary." (Shiyou Li et al.,2010)

Aesculus californica - California buckeye

"Nuts processed into mush and served with pit oven-cooked deer meat, seafood, roasted peppernuts, and contemporary picnic foods within the living memory of Kashaya Pomo individuals (Ortiz 1989a: 25)" (Ortiz,GTR)

"Aesculus californica (Spach.) Nutt. Berraco; chattYa (M), chatch (R). Fruits eaten, after leaching; bark used in decoctions for toothache, loose teeth; salve of pulverized fruits applied to hemorrhoids; fruits used in preparation of fish poison. (1)" (Bocek)

Aesculus chinensis

"In Chinese herbal medicine, the seed of a related plant, A. chinensis, is used to treat malnutrition and other digestive difficulties at a dose of 3 to 9 grams in decoction. Japanese herbal medicine prescribes the seed of A. turbinata, another related plant, to treat digestive difficulties and promote absorption.80" [Boik NCCT]

"In China, the seeds of A. chinensis var. chinensis have been used as a stomachic and analgesic in the treatment of distention and pain in chest and abdomen, malaria, and dysentery 10 and tablets made from the seeds are also used for treating heart diseases 11." (Shiyou Li et al.,2010)

"Aesculus chinensis is native to China and is distributed mainly in the Hebei, Henan, and Shanxi provinces. The fruits of this species usually are smooth subglobose, truncate to slightly impressed at the apex, thickly walled with smaller seeds having proportionately larger hilum. The surface of its petiolulate leaflets is glabrous or sparingly pilose [2]. Its seeds, called "Sha Luo Zhi" in traditional Chinese medicine, have long been used as a stomachic and analgesic in the treatment of distention and pain in chest and abdomen, ma- laria, and dysentery [10]. Additionally, the tablets made from the seeds are used for treating heart diseases [11]." (Shiyou Li et al.,2010)

Aesculus indica

Aesculus indica (Colebr. Ex. Cambess.) Hook. "Ethnomedicinal uses: Oil from the seeds is externally applied against rheumatism. Seeds are given to horses in colic pain." (Kumar et al.,2009)

"Aesculus indica, known as Indian horse chestnut, is found on mountain slopes or in moist and shady valleys in the northwestern Himalayan forests. It is distributed from Nepal northwestward into the State of Kashmir in north India, and across the Indus River to West Pakistan and to northeastern Afghanistan. Its fruits are reddish brown, smooth ovoids. The petiolulate leaflets of this species are submembranacous with finely serrate margin [2]. In some parts of Himachal Pradesh, the seeds are dried and grounded into flour, called tattwakhar. This flour is bitter and used for making halwa, which is taken as phalahar (non-cereal food) during fasts; the leaves are used as a fodder for cattle. India horse chestnut also has medicinal properties for animals and human beings. The fruits are given to horses suffering from colic. The oil extracted from the seeds is used to cure rheumatism [21]." (Shiyou Li et al.,2010)

Aesculus pavia

"Recently, a new prenylated coumarin with antifungal activity, pavietin (161), was isolated and identified from the leaves of A. pavia [67]." (Shiyou Li et al.,2010)

Aesculus turbinata

"Aesculus turbinata, known as Japanese horse chestnut, is native only to Japan. It has been found on the island of Hokkaido and the central and northern parts of Honshu. This species has been widely cultured in England, the United States, and China. This species is similar to A. hippocastanum, differently mainly in the slightly smaller flowers, warty fruit surface, and in the larger leaves, which are glaucescent beneath and have more regularly crenate-serrate margins [2]. The seeds of the Japanese horse chestnut have been used as an emergency provision since ancient times and utilized traditionally in Japan as a confectionery ingredient in rice cakes and rice balls [19]. Its seed extract in combination with spirits have also been used as a folk medicine for the treatment of bruises and sprains in some regions of Japan [20]." (Shiyou Li et al.,2010)

"The seeds of A. turbinata also contain rich triterpenoid saponins as the main components. A number of investigations on the seeds of Japanese horse chestnut resulted in the isolation and structure determination of 16 polyhydroxylated triterpenoid saponins." (Shiyou Li et al.,2010)

References

  • (Anicic,2011) Aničić, M., et al. "Trace elements accumulation and temporal trends in leaves of urban deciduous trees (Aesculus hippocastanum and Tilia spp.)." Ecological Indicators 11.3 (2011): 824-830.
  • (baraldi2007) Baraldi, Cecilia, et al. "Chemical composition and characterisation of seeds from two varieties (pure and hybrid) of Aesculus hippocastanum." Food chemistry 104.1 (2007): 229-236.
  • (Bocek) Bocek, Barbara R. "Ethnobotany of costanoan Indians, California, based on collections by John P. Harrington." Economic Botany 38.2 (1984): 240-255.
  • (chung1998) Chung, King-Thom, et al. "Tannins and human health: a review." Critical reviews in food science and nutrition 38.6 (1998): 421-464.
  • Duke - http://www.ars-grin.gov/cgi-bin/duke/ethnobot.pl?Aesculus%20hippocastanum Accessed Dec 23, 2014
  • E-Flora BC, E-flora - http://ibis.geog.ubc.ca/biodiversity, Electronic Atlas of the Flora of British Columbia, Klinkenberg, Brian. (Editor) 2013. E-Flora BC: Electronic Atlas of the Flora of British Columbia (eflora.bc.ca). Lab for Advanced Spatial Analysis, Department of Geography, University of British Columbia, Vancouver.
  • (facino1995) Facino, Roberto Maffei, et al. "Anti‐elastase and anti‐hyaluronidase activities of saponins and sapogenins from Hedera helix, Aesculus hippocastanum, and Ruscus aculeatus: factors contributing to their efficacy in the treatment of venous insufficiency." Archiv der Pharmazie 328.10 (1995): 720-724.
  • Herbs2000 - Aesculus hippocastanum, Accessed May 18, 2014
  • (guarrera1999) Guarrera, Paolo Maria. "Traditional antihelmintic, antiparasitic and repellent uses of plants in Central Italy." Journal of ethnopharmacology 68.1-3 (1999): 183-192.
  • (gurib-fakim2006) Gurib-Fakim, Ameenah. "Medicinal plants: traditions of yesterday and drugs of tomorrow." Molecular aspects of Medicine 27.1 (2006): 1-93.
  • (Hubner,1999) Hübner, Gabriele, Victor Wray, and Adolf Nahrstedt. "Flavonol oligosaccharides from the seeds of Aesculus hippocastanum." Planta Medica 65.07 (1999): 636-642.
  • (Irving H. Isenberg) Isenberg, Irving H. "Papermaking fibers." Economic Botany 10.2 (1956): 176-193.
  • Jepson2012 - William J. Stone, 2012. Aesculus, in Jepson Flora Project (eds.), Jepson eFlora, http://ucjeps.berkeley.edu/cgi-bin/get_IJM.pl?tid=12026, accessed on Mar 6 2014, January 10, 2019.
  • (kapusta2007) Kapusta, Ireneusz, et al. "Flavonoids in horse chestnut (Aesculus hippocastanum) seeds and powdered waste water byproducts." Journal of agricultural and food chemistry 55.21 (2007): 8485-8490.
  • (kim1994) Kim, Nicholas D., and Jack E. Fergusson. "Seasonal variations in the concentrations of cadmium, copper, lead and zinc in leaves of the horse chesnut (Aesculus hippocastanum L.)." Environmental Pollution 86.1 (1994): 89-97.
  • (konoshima1986) Konoshima, Takao, and Kuo-Hsiung Lee. "Antitumor agents, 82. Cytotoxic sapogenols from Aesculus hippocastanum." Journal of natural products 49.4 (1986): 650-656.
  • (Kumar et al.,2009) Kumar, Mahesh, Yash Paul, and V. K. Anand. "An ethnobotanical study of medicinal plants used by the locals in Kishtwar, Jammu and Kashmir, India." Ethnobotanical leaflets 2009.10 (2009): 5.
  • (matsuda1997) Matsuda, Hisashi, et al. "Antiinflammatory effects of escins Ia, Ib, IIa, and IIb from horse chestnut, the seeds of Aesculus hippocastanum L." Bioorganic & Medicinal Chemistry Letters 7.13 (1997): 1611-1616.
  • (Ortiz,GTR) Ortiz, Beverly R. "Contemporary California Indians, oaks and sudden oak death (Phytophthora ramorum)." In: Merenlender, Adina; McCreary, Douglas; Purcell, Kathryn L., tech. eds. 2008. Proceedings of the sixth California oak symposium: today's challenges, tomorrow's opportunities. Gen. Tech. Rep. PSW-GTR-217. Albany, CA: US Department of Agriculture, Forest Service, Pacific Southwest Research Station: pp. 39-56. Vol. 217. 2008.
  • (P.-G. Gülz et al.) Gülz, P-G., E. Müller, and T. Herrmann. "Chemical composition and surface structures of epicuticular leaf waxes from Castanea sativa and Aesculus hippocastanum." Zeitschrift für Naturforschung C 47.9-10 (1992): 661-666.
  • (Pieroni, Andrea, et al.) Pieroni, Andrea, et al. "Ethnopharmacognostic survey on the natural ingredients used in folk cosmetics, cosmeceuticals and remedies for healing skin diseases in the inland Marches, Central-Eastern Italy." Journal of Ethnopharmacology 91.2-3 (2004): 331-344.
  • PFAF - Aesculus hippocastanum, Plants For A Future, http://www.pfaf.org/user/Plant.aspx?LatinName=Aesculus+hippocastanum, Accessed Jan 12, 2015
  • (Podolak et al,2010) Podolak, Irma, Agnieszka Galanty, and Danuta Sobolewska. "Saponins as cytotoxic agents: a review." Phytochemistry Reviews 9.3 (2010): 425-474.
  • (Redzic,2007) S Redžić, Sulejman. "The ecological aspect of ethnobotany and ethnopharmacology of population in Bosnia and Herzegovina." Collegium antropologicum 31.3 (2007): 869-890.
  • (Saric-kundalic et al., 2010) Šarić-Kundalić, Broza, et al. "Ethnobotanical study on medicinal use of wild and cultivated plants in middle, south and west Bosnia and Herzegovina." Journal of ethnopharmacology 131.1 (2010): 33-55.
  • (Shiyou Li et al.,2010) Li, Shiyou, Xiao-Yuan Lian, and Zhizhen Zhang. "An overview of genus Aesculus L.: ethnobotany, phytochemistry, and pharmacological Activities." (2010).
  • Wiki - Aesculus hippocastanum, Wikipedia.org, https://en.wikipedia.org/wiki/Aesculus_hippocastanum
    • [3] Rushforth, K. (1999). Trees of Britain and Europe. Collins ISBN 0-00-220013-9.
    • [5] Euro+Med Plantbase Project: Aesculus hippocastanum Archived September 28, 2007, at the Wayback Machine.
  • (wilkinson1999) Wilkinson, J. A., and A. M. G. Brown. "Horse Chestnut–Aesculus hippocastanum: Potential applications in cosmetic skin‐care products." International journal of cosmetic science 21.6 (1999): 437-447.
  • (Yilmaz,2006) Yilmaz, Ruya, et al. "Use of Aesculus hippocastanum L. as a biomonitor of heavy metal pollution." Pak. J. Bot 38.5 (2006): 1519-1527.

Image References

  • 1, Chestnut inflorescences (Aésculus hippocástanum), Ввласенко, CC BY-SA 3.0 , via Wikimedia Commons
  • 2, Fruit de marronnier (Aesculus hippocastanum), Gzen92, CC BY-SA 4.0 , via Wikimedia Commons

Journals of Interest

  • Yılmaz, R., S. Sakcalı, C. Yarcı, A. Aksoy and M. Ozturk, 2006. Use of Aesculus hippocastanum L. as a biomonitor of heavy metal pollution. Pak. J. Bot., 38(5): 1519-1527.
  • Kim, N.D., Fergusson, J.E., 1994. Seasonal variations in the concentrations of cadmium, copper, lead and zinc in leaves of the horse chesnut (Aesculus hip- pocastanum L.). Environ. Pollut. 86, 89–97.
  • De La Montana Miguelez, J., Miguez Bernardez, M., & Garcia Queijeiro, J. M. (2004). Composition of varieties of chestnuts from Galicia (Spain). Food Chemistry, 84, 401–404.
  • Deli, J., Matus, Z., & Toth, G. (2000). Comparative study on the carotenoid composition in the buds and flowers of different Aesculus species. Chromatographia, 51, 179–182.
  • Deli, J., Molnar, P., Matus, Z., Toth, G., Steck, A., Niggli, U. A., et al. (1998). Aesculaxanthin, a new carotenoid isolated from pollens of Aesculus hippocastanum. Helvetica Chimica Acta, 81, 1815–1820.
  • Facino RM, Carini M, Stefani R, Aldini G, Saibene L: Anti-elastase and anti-hyaluronidase activities of saponins and sapogenins from Hedera helix, Aesculus hippocastanum, and Ruscus aculeatus: factors contributing to their efficacy in the treat- ment of venous insufficiency. Arch Pharm (Weinheim) 1995, 328:720-4.
  • Konoshima, T., & Lee, K. H. (1986). Antitumor agents, 82. Cytotoxic sapogenols from Aesculus hippocastanum. Journal of Natural Prod- ucts, 49, 650–656.
  • Wei, F., Ma, L. Y., Cheng, X. L., Lin, R. C., Jin, W. T., Khan, I. A., et al. (2005). Preparative HPLC for purification of four isomeric bioactive saponins from the seeds of Aesculus chinensis. Journal of Liquid Chromatography and Related Technologies, 28, 763–773.
  • Yang, X. W., Zhao, J., Cui, Y. X., Liu, X. H., Ma, C. M., Hattori, M., et al. (1999). Anti-HIV-1 protease triterpenoid saponins from the seeds of Aesculus chinensis. Journal of Natural Products, 62, 1510–1513.
  • Yoshikawa, M., Murakami, T., Matsuda, H., Yamahara, J., Murakami, N., & Kitagawa, I. (1996). Bioactive saponins and glycosides. 3. Horse chestnut. Chemical & Pharmaceutical Bulletin, 44, 1454–1464.
  • Newell, E.A. (1991) Direct and delayed costs of reproduction in Aesculus californica. Journal of Ecology 79, 365–378.
  • Zhang Z, Li S (2007) Cytotoxic triterpenoid saponins from the fruits of Aesculus pavia L. Phytochemistry 68:2075–2086

Data Analytics

Source Material Depth

This graph represents the unique prevalence of "Aesculus" within the Eflora local research library. Penetration indicates the percentage of total documents containing at least one of the search terms.

Unique Sources: Books
125 / 943 vols
Unique Sources: Journals
34 / 1459 articles
Total Page Hits (Pages containing search term(s))
637 cumulative